EurekaMag PDF full texts Chapter 42,287

Koper, R. 1981: Anti-sperm antibodies as a cause of sterility. Ginekologia Polska 52(5): 471-474

Srpová, M.T. 1980: Anti-sperm antibodies in women and functional sterility. Ceskoslovenska Gynekologie 45(1): 39-47

Hancock, R.J.; Duncan, D.; Carey, S.; Cockett, A.T.; May, A. 1983: Anti-sperm antibodies, HLA antigens, and semen analysis. Lancet 2(8354): 847-848

Greco, L.; Misuraca, G.; Leone, E. 1973: Anti-spermatogenic effect of seminal ribonuclease (BS-1 RNase). Bollettino della Societa Italiana di Biologia Sperimentale 49(24): 1439-1444

Tapchaisri, P.; Chomcharn, Y.; Poonthong, C.; Asavanich, A.; Limsuwan, S.; Maleevan, O.; Tharavanij, S.; Harinasuta, T. 1983: Anti-sporozoite antibodies induced by natural infection. American Journal of Tropical Medicine and Hygiene 32(6): 1203-1208

Fernandez-Alonso, G.I.; Victorero, C.O.; Meiss, R.P.; Conti, C.J. 1984: Anti-squamous basal cell antibody activity in Waldenström's macroglobulinemia. Journal of Cutaneous Pathology 11(2): 154-157

Yourassowsky, E.; Vanderlinden, M.P. 1973: Anti-staphylococcal action of minocycline. Acta Clinica Belgica 28(1): 13-16

Kojima, R. 1972: Anti-staphylococcal activities of mitomycin derivatives and its relationship to antileukemic effects. Igaku to Seibutsugaku. Medicine and Biology 84(1): 27-32

Sabath, L.D.; Munyan, M.; Mach, P. 1982: Anti-staphylococcal activity of a penem, Sch 29482. Journal of Antimicrobial ChemoTherapy 9 Suppl C: 189-194

Krotova, T.A.; Gerasimova, M.V.; Rozanova, L.M.; Beresneva, I.A.; Eremina, T.N. 1970: Anti-staphylococcal antibodies in the serum of patients with acute leukosis. Problemy Gematologii i Perelivaniia Krovi 15(9): 19-21

Mirzoev, M. 1969: Anti-staphylococcal bactericidal activity of leukocyte extract. Archives Roumaines de Pathologie Experimentales et de Microbiologie 28(2): 379-387

Robertson, M.H.; Hoy, G.; Peterkin, I.M. 1980: Anti-static mattress as reservoir of pseudomonas infection. British Medical Journal 280(6217): 831-832

Mascetelli-Coriandoli, E.; Lanzani, P. 1965: Anti-steatogenic and anti-thyrotoxic effect of an extracted fraction of swine liver. Bollettino della Societa Italiana di Biologia Sperimentale 41(12): 664-666

Bergamaschi Dallorso, M.; Cappa, E. 1969: Anti-steatogenic hepatic action of 5,6-dimethylbenzimidazolyl-cobamide-coenzyme. Bollettino della Societa Italiana di Biologia Sperimentale 45(22): 1385-1388

Jung-Testas, I.; Baulieu, E.E. 1984: Anti-steroid action in cultured L-929 mouse fibroblasts. Journal of Steroid Biochemistry 20(1): 301-306

Mirecka, J. 1980: Anti-steroid antibodies and their application for immunohistochemical localization of sex hormones. Acta Histochemica. Supplementband 22: 245-251

Pinto, M.; Rimon, A. 1970: Anti-steroid factors in normal and pathological human sera. Vox Sanguinis 18(2): 155-162

Eyquem, A.; de Saint Martin, J. 1971: Anti-stomach antibodies. Revue Francaise d'Allergologie 11(3): 239-248

Herbeuval, R.; Duheille, J.; Cuny, G.; Haagen, A. 1967: Anti-stomach antibodies and aging. La Presse Medicale 75(15): 731-735

Senchik, R.V.; Chebochkevich, V.N. 1973: Anti-stomach antibodies in hypoferrous anemia. Terapevticheskii Arkhiv 45(9): 122-126

Yu, P.K.; Washington, J.A. 1982: Anti-streptococcal activity of Sch 29482--a novel penem antibiotic. Journal of Antimicrobial ChemoTherapy 9 Suppl C: 195-198

Okuhara, K.; Yoshimoto, M.; Fujisawa, S.; Watanabe, Y.; Okuda, R. 1983: Anti-streptococcal cell membrane and anti-human glomerular basement membrane titers in sera of patients with poststreptococcal acute glomerulonephritis and anaphylactoid purpura. Japanese Circulation Journal 47(11): 1293-1297

Nakamura, Y.; Abe, Y.; Mikuni, K.; Watanabe, N.; Hayano, S. 1983: Anti-streptococcal esterase (ASE) and ASO in streptococcal infections in children. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 57(9): 771-775

Toto, P.D.; Wittwer, J.W.; Dickler, E.H. 1968: Anti-streptococcal hyaluronidase and periodontitis. Journal of Dental Research 47(1): 174

Koshi, G. 1971: Anti-streptolysin O test by microtechnique. Indian Journal of Medical Research 59(10): 1554-1555

Fukuoka, Y. 1968: Anti-streptolysin-O and anti-hyaluronidase. Nihon Rinsho. Japanese Journal of Clinical Medicine 26(2): 357-370

Lishmanov, I.B.; Amosova, E.N.; Slepushkin, V.D.; Iremenko, K.V. 1984: Anti-stress effect of D-Ala2-Leu5-Arg6-enkephalin. Biulleten' Eksperimental'noi Biologii i Meditsiny 98(8): 199-200

Andreev, B.V.; Ignatov, I.D.; Nikitina, Z.S.; Sytinskiĭ, I.A. 1982: Anti-stress role of the GABA-ergic system of the brain. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 32(3): 511-519

Malyshev, V.V.; Dvoretskaia, T.P.; Kazimirovskaia, V.B.; Kameneva, N.S.; Smakolina, E.I. 1985: Anti-stressor effect of 1-chloromethylsilatrane. Doklady Akademii Nauk SSSR 285(5): 1249-1251

Wiedermann, G.; Denk, H.; Kovac, W. 1967: Anti-subcellular liver cell fraction oriented serum factors in rats II. Studies on the biological significance in vivo. Zeitschrift für Immunitatsforschung Allergie und Klinische Immunologie 134(4): 357-363

Perloff, M.M. 1971: Anti-substitution law repeal--pro and con: the case against repeal. American Journal of Pharmacy and the Sciences Supporting Public Health 143(1): 15-23

Swanson, W.C. 1971: Anti-suicide service in new Orleans. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 123(3): 83-90

Denoël, A. 1968: Anti-sunburn preparations. Il Farmaco; Edizione Pratica 23(6): 277-315

Dosch, H.M.; Matheson, D.; Schuurman, R.K.; Gelfand, E.W. 1980: Anti-suppressor cell effects of lithium in vitro and in vivo. Advances in Experimental Medicine and Biology 127: 447-462

Charpin, J.; Vague, P.; Aubert, J.; Vervloet, D.; Anfosso-Capra, F.; Di Campo, C. 1974: Anti-synthetic beta-1-24 corticotropin antibodies. Biomedicine / 21(8): 349-352

Escande, J.P.; Enjolras, O. 1973: Anti-syphilis immunization. La Nouvelle Presse Medicale 2(20): 1383-1386

Wicken, A.J.; Gibbens, J.W.; Knox, K.W. 1972: Anti-teichoic acid antibodies and non-treponemal serological tests for syphilis. Infection and Immunity 5(6): 982-984

Gómez Garcés, J.L.; Aquilar Alfaro, L.; Soriano García, F. 1982: Anti-teichoic-acid antibodies is staphylococcal infections. Revista Clinica Espanola 164(3): 169-172

Brun, J.; Gilly, R.; Biot, N.; Perrin-Fayolle, M.; Kofman, J. 1968: Anti-tensile power of serum with an elevated elastase level in mucoviscidosis in children and its variations in adult emphysema. Journal Francais de Medecine et Chirurgie Thoraciques 22(6): 663-673

Dondero, F.; Isidori, A. 1972: Anti-testicular autoimmunization in man. Annales d'Endocrinologie 33(4): 417-425

Matveev, K.I.; Skurkovich, S.V.; Bychenko, B.D.; Papko, G.F.; Lukovkina, E.N. 1973: Anti-tetanus gamma-globulin from donor blood and its effectiveness in the prevention of tetanus. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(10): 38-43

Ruiz Merino, J. 1982: Anti-tetanus immunity and vaccination by the lingual route. Revista de Sanidad E Higiene Publica 56(5-6): 469-477

Ceddia, T.; Marinucci, M.C.; Zepponi, E. 1982: Anti-tetanus immunity in Aquila residents. Bollettino della Societa Italiana di Biologia Sperimentale 58(19): 1256-1259

Karavanov, A.G.; Kovtunovich, L.G.; Nazarchuk, L.V.; Mikhno, A.P. 1970: Anti-tetanus immunoglobulin from retroplacental serum. Klinicheskaia Khirurgiia 12: 24-28

Vecchi, A.; Morini, C.; Tedeschi, M.; Gabbi, E.; Farinetti, A.; Calonghi, G.F. 1985: Anti-tetanus protection in a homogeneous group of vaccinated subjects from the city of Reggio Emilia. Bollettino Dell'istituto Sieroterapico Milanese 64(6): 486-489

Grosbuis, S. 1974: Anti-tetanus serum or anatoxin?. La Revue du Praticien 24(51): 4505-4506; 4509-4511

Nies, K.; Boyer, R.; Stevens, R.; Louie, J. 1980: Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses. Arthritis and Rheumatism 23(12): 1343-1350

Spînu, I.; Pencea, I.; Lascu, N.; Lazăr, M.; Hoişie, S.; Puiu, A.; Georgescu, M.; Hurjui, J. 1967: Anti-tetanus vaccination in the aged. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 71(3): 693-698

Bizzini, B. 1983: Anti-tetanus vaccines. Bollettino Dell'istituto Sieroterapico Milanese 62(6): 550-554

Pontecorvo, M. 1980: Anti-tetanus vaccines, serums and immunoglobulins. Bollettino Dell'istituto Sieroterapico Milanese 59(5): 448-454

Eastman, N. 1995: Anti-therapeutic community mental health law. Bmj 311(7006): 689

Calman, K.C. 1995: Anti-therapeutic community mental health law. Chief medical officer defends the Mental Health Bill. Bmj 310(6993): 1530

Moore, R. 1995: Anti-therapeutic community mental health laws. National Schizophrenia Fellowship is highly critical of government's proposals. Bmj 310(6993): 1530

Schlesinger, M. 1970: Anti-theta antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC. Nature 226(5252): 1254-1256

Rouse, B.T.; Röllinghoff, M.; Warner, N.L. 1972: Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour. Nature: New Biology 238(82): 116-117

Zamboni, P.; Persichella, M.; Siro-Brigiani, G.; De Luca, A. 1984: Anti-thirst action of propranolol. Bollettino della Societa Italiana di Biologia Sperimentale 60(7): 1377-1379

O'Brien, J.R. 1974: Anti-thormbin IIi and heparin clotting times in thrombosis and atherosclerosis. Thrombosis et Diathesis Haemorrhagica 32(1): 116-123

Mathews, M.B.; Reichlin, M.; Hughes, G.R.; Bernstein, R.M. 1984: Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. Journal of Experimental Medicine 160(2): 420-434

Tan, S.H.; Doraisamy, G.; Noriah, R.; Lopez, C.G. 1983: Anti-thrombin IIi levels in some Malaysian patients suspected of having acquired coagulation disorders. Singapore Medical Journal 24(1): 33-36

Ott, H.; Smith, G.M. 1971: Anti-thrombotic activity of a benzo(c)(1,6)naphthyridine. British Journal of Pharmacology 43(2): 460P-461P

Bicher, H.I. 1970: Anti-thrombotic effect of an heparin-like substance (SP 54) preventing red cell and platelet aggregation. Arzneimittel-Forschung 20(3): 379-381

Srivastava, R.; Dikshit, M.; Srimal, R.C.; Dhawan, B.N. 1985: Anti-thrombotic effect of curcumin. Thrombosis Research 40(3): 413-417

Paris, J.; Fournau, P.; Granero, M.; Viens, C. 1983: Anti-thrombotic effect of very low doses of acetyl salicylic acid in rats. Thrombosis Research 29(3): 313-321

Roth, D.M.; Lefer, A.M.; Smith, J.B.; Nicolaou, K.C. 1982: Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives. Prostaglandins Leukotrienes and Medicine 9(5): 503-509

Luriia, E.A.; Domashneva, I.V. 1973: Anti-thymocyte antibodies in the serum of patients with schizophrenia. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(12): 1873-1878

Sabbe, L.J.; Claas, F.H.; Haak, H.L.; van Gemert, G.W.; Jansen, J.; Zwaan, F.E.; Tricot, G.; Niterink, A.; Langerak, J.; van Rood, J.J. 1981: Anti-thymocyte globulin (ATG) can eliminate platelet refractoriness. Blut 42(6): 331-335

Jansen, J.; Veenhof, W.F.; Goselink, H.M. 1981: Anti-thymocyte globulin effective in the treatment of aplastic anemia does not stimulate granulocyte precursor cells. Experimental Hematology 9(10): 1028-1034

Collste, L.G.; Franksson, C.; Groth, C.G.; Jacobson, S.; Magnusson, G.; Schantz, B.; Svehag, S.E.; Werner, B. 1971: Anti-thymocyte globulin for immunosuppression. Nordisk Medicin 86(46): 1358

Jansen, J.; Zwaan, F.E.; Haak, H.L.; te Velde, J.; Guiot, H.F.; Sabbe, L.J.; Eernisse, J.G.; Tricot, G.J.; van Rood, J.J. 1982: Anti-thymocyte globulin treatment for aplastic anemia. Scandinavian Journal of Haematology 28(4): 341-351

Murisasco, A.; Pollini, J.; Saingra, S.; Barnouin, F.; Lafon, S.; Mostefa-Kara, S.; Latour, M. 1972: Anti-thymocyte globulins: clinical trials during kidney transplantation. Marseille Medical 109(9): 541-548

Kodo, H.; Harada, M.; Hattori, K. 1983: Anti-thymocyte serum and bone marrow transplantation. I. Effect of anti-mouse thymocyte serum on hematopoietic stem cells. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(1): 183-189

Kodo, H.; Harada, M.; Hattori, K. 1983: Anti-thymocyte serum and bone marrow transplantation. II. Specificity and immunosuppressive activity. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(4): 852-858

Collste, L.G. 1972: Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration. Acta Chirurgica Scandinavica 138(7): 661-666

Bachvaroff, R.; Galdiero, F.; Grabar, P. 1969: Anti-thymus cytotoxicity: identification and isolation of rat thymus-specific membrane antigens and purification of the corresponding antibodies. Journal of Immunology 103(5): 953-961

Lee, L.S. 1982: Anti-thyroglobulin and anti-thyroid microsomal antibodies in thyroid disorders. Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 15(3): 202-211

De Medeiros-Neto, G.A.; Martits, A.M.; Cintra, A.B. 1971: Anti-thyroglobulin antibodies: results obtained with sera of patients with various thyroid diseases. Amb: Revista da Associacao Medica Brasileira 17(12): 387-398

Jaeger, K.H.; Goslar, H.G.; Grigoriadis, P.G.; Back, N. 1984: Anti-thyroid activity of purified thymus gland extract in male Wistar rats. Pharmacological Research Communications 16(6): 559-577

Peracchi, M.; Cavagnini, F.; Ghislanzoni, G. 1971: Anti-thyroid antibodies and autoimmune diseases in patients with vitiligo. Giornale Italiano di Dermatolotia. Minerva Dermatologica 46(11): 487-491

Pencea, V.; Scripcaru, G.; Jacotă, L.; Popescu, C.; Schapira, A.; Harmanschi, A. 1969: Anti-thyroid autoantibodies in patients with gonadal dysgenesis. Studii Si Cercetari de Endocrinologie 20(2): 141-146

Pencea, V.; Baran, T.; Popescu, C.; Zbranca, E. 1967: Anti-thyroid autoimmunization in endemic cretinism with goiter. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 71(3): 723-726

Depisch, D.; Dinstl, K.; Keminger, K. 1971: Anti-thyroid drugs--a cause of liability to bleeding during thyroid surgery. Acta Endocrinologica 68(1): 164-168

Akamizu, T.; Kosugi, S.; Kohn, L.D.; Mori, T. 1994: Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach. Nihon Rinsho. Japanese Journal of Clinical Medicine 52(4): 1024-1030

Malley, A.; Deppe, L. 1980: Anti-timothy IgE formation: suppression with antigen D-dGl conjugates. International Archives of Allergy and Applied Immunology 63(1): 113-120

Ablin, R.J. 1972: Anti-tissue IgG antibodies and deficiency of IgA. Vox Sanguinis 23(4): 371-375

Homberg, J.C. 1970: Anti-tissue antibodies in human pathology. Nouvelle Revue Francaise d'Hematologie 10(3): 339-354

Alekseeva, O.G. 1970: Anti-tissue antibodies in radiation injury. Radiobiologiia 10(5): 753-755

Tsolov, R.; Matev, M.; Nedelcheva, E.; Toshkov, A.; Kekhaiov, I. 1972: Anti-tissue antibodies in some non-tuberculous lung diseases. Vutreshni Bolesti 11(3): 34-37

Bazarnova, M.A. 1971: Anti-tissue antibodies in systemic diseases of the blood. Problemy Gematologii i Perelivaniia Krovi 16(9): 3-8

Kusukawa, R.; Sakamoto, T.; Milgrom, F. 1968: Anti-tissue antibodies in the sera and urine of patients with nephritis. Arerugi 17(9): 731-736

Ardry, R.; Courtin, A.; Thu, N.T. 1966: Anti-tissue antibodies, regulators of cell activity. Annales Pharmaceutiques Francaises 24(11): 717-734

Ruffatti, A.; Visentin, G.; Giordano, C.; Bozzo, R.; De Silvestro, G.; Todesco, S. 1983: Anti-tissue autoantibodies in malignant pulmonary neoplasms. Minerva Medica 74(22-23): 1319-1324

Pokrovskiĭ, V.I.; Sachkov, V.I.; Matveeva, S.M.; Vengerov, I.I.; Gromoglasova, E.V. 1972: Anti-tissue circulating antibodies in meningococcal infections. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(12): 73-77

Aiache, J.M.; Cheminat, J.C.; Lakatos, M.; Molina, C. 1972: Anti-tobacco precipitins and respiratory tract diseases. Revue de Tuberculose et de Pneumologie 36(2): 301-307

Glenn, T.M.; Lefer, A.M. 1971: Anti-toxic action of methylprednisolone in hemorrhagic shock. European Journal of Pharmacology 13(2): 230-238

Das, M.; Ganguly, D.K.; Vedasiromoni, J.R. 1980: Anti-tremor action of C10Dichol, a peripheral acetylcholine synthesis inhibitor. British Journal of Pharmacology 71(1): 349-353

Achari, G.; Sinha, S.P. 1967: Anti-tremor action of propranolol (Inderal). Japanese Journal of Pharmacology 17(4): 679-680

Leonard, B.E. 1972: Anti-tremorine effects of some mono- and diacyloxytropanes. Archives Internationales de Pharmacodynamie et de Therapie 196(1): 93-97

Rodríguez-Espinosa, J.; Ordóñez-Lianos, J.; Gómez-Gerique, J.A.; Mora, J. 1984: Anti-triiodothyronine autoantibodies interfere with two recently commercialized radioimmunoassays for free triiodothyronine. Clinical Chemistry 30(1): 151-152

Barber, P.; Rittenberg, M.B. 1969: Anti-trinitrophenyl (TNP) antibody detection by neutralization of TNP-coliphage T4. Immunochemistry 6(2): 163-174

Isa, A.M. 1973: Anti-trinitrophenyl (TNP) antibody response: suppression by anti-macrophage serum. Research Communications in Chemical Pathology and Pharmacology 5(1): 163-172

Lim, S.S.; Tu, Z.H.; Lemanski, L.F. 1984: Anti-troponin-T monoclonal antibody crossreacts with all muscle types. Journal of Muscle Research and Cell Motility 5(5): 515-526

Jones, K.B. 1982: Anti-trust implications of maximum fee setting. Pennsylvania Medicine 85(10): 25

Jones, K.B. 1981: Anti-trust violations and practicing physicians. Pennsylvania Medicine 84(7): 17-18

Schmid, P.C. 1980: Anti-tubercular agents and their use in children. Fortschritte der Medizin 98(44): 1731-1734

Zablotniak, R. 1970: Anti-tuberculosis School League (1923-1939). Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 38(10): 1019

Toyoara, M.; Iwasaki, T. 1971: Anti-tuberculosis activity of rifampicin for experimental tuberculosis of mice. Kekkaku: 46(1): 19-22

Gayet, A.M. 1982: Anti-tuberculosis campaign and medico-social aspects of tuberculosis. Soins; la Revue de Reference Infirmiere 27(9): 46-47

Yamashita, K. 1970: Maternal and infant health services in Ishimaki City. Japanese Journal for Public Health Nurse 26(3): 46-50

Ball, P. 1968: Some apparently common problems in patients receiving contraceptive pills. Nebraska State Medical Journal 53(9): 428-432

Chenebault, J.; Lahlou, M.; Burzoni, F. 1970: Anti-tuberculosis dispensary in a developing country. Bulletin de l'Academie Nationale de Medecine 154(17): 382-393

Babolini, G. 1967: Anti-tuberculosis immunology campaign in 1966 developed by the Clinica Tisiologica dell'Università Messina. Lotta Contro la Tubercolosi 37(1 Suppl): 61-66

Gotti, D. 1970: Anti-tuberculosis vaccination with SDV (Salvioli's diffusing vaccine) in the second decade of its use. La Clinica Pediatrica 52(6): 255-270

Jentgens, H. 1973: Anti-tuberculous chemotherapy during pregnancy. Praxis der Pneumologie 27(8): 479-488

Rousset, B.; Bernier-Valentin, F.; Poncet, C.; Orgiazzi, J.; Madec, A.M.; Monier, J.C.; Mornex, R. 1983: Anti-tubulin antibodies in autoimmune thyroid disorders. Clinical and Experimental Immunology 52(2): 325-332

Rousset, B.; Vialettes, B.; Bernier-Valentin, F.; Vague, P.; Beylot, M.; Mornex, R. 1984: Anti-tubulin antibodies in recent onset type 1 (insulin-dependent) diabetes mellitus: comparison with islet cell antibodies. Diabetologia 27(4): 427-432

Berdel, W.E.; Bausert, W.R.; Fink, U.; Rastetter, J.; Munder, P.G. 1981: Anti-tumor action of alkyl-lysophospholipids (Review). Anticancer Research 1(6): 345-352

Higami, Y.; Yu, B.P.; Shimokawa, I.; Bertrand, H.; Hubbard, G.B.; Masoro, E.J. 1995: Anti-tumor action of dietary restriction is lesion-dependent in male Fischer 344 rats. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 50(2): B72-B77

Umezawa, I. 1970: Anti-tumor activity and side reaction of bacterial component. Japanese Journal of Antibiotics 23(3): 287-297

Bloom, E.T.; Fahey, J.L.; Peterson, I.A.; Geering, G.; Bernhard, M.; Trempe, G. 1973: Anti-tumor activity in human serum: antibodies detecting blood-group-A-like antigen on the surface of tumor cells in culture. International Journal of Cancer 12(1): 21-31

Shibuya, N.; Yoshida, J.; Kobayashi, T.; Kageyama, N. 1983: Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent. No Shinkei Geka. Neurological Surgery 11(4): 361-367

Ogura, T.; Sakaya, M.; Naniwa, M.; Yamamura, Y. 1980: Anti-tumor activity of BCG-CWS. Kekkaku: 55(10): 470-472

Zunino, F.; Giuliani, F.; Savi, G.; Dasdia, T.; Gambetta, R. 1982: Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid. International Journal of Cancer 30(4): 465-470

Yamaguchi, N.; Sakai, T.; Yoshida, S.; Katayama, Y.; Kawai, K. 1983: Anti-tumor activity of endotoxin depends on activation of serum complement fragments. Gastroenterologia Japonica 18(5): 436-439

Kikuchi, H.; Manda, T.; Kobayashi, K.; Yamada, Y.; Iguchi, K. 1983: Anti-tumor activity of lemnalol isolated from the soft coral Lemnalia tenuis Verseveldt. Chemical and Pharmaceutical Bulletin 31(3): 1086-1088

Horie, K.; Yamasaki, T.; Nishimura, K.; Tsuchiya, S.; Yoshizawa, A.; Akimoto, R.; Watanabe, H.; Shirasawa, K.; Suzuki, M.; Tsujimoto, Y. 1984: Anti-tumor activity of peripheral lymphocytes of tumor-bearing rats by in vitro culture. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(6): 1269-1275

Gavrilenko, I.S.; Sokolova, I.P.; Saiapin, A.V.; Ivnitskiĭ, I.I. 1983: Anti-tumor activity of the polysaccharide mannan, and its effect on the dynamics of cyclic nucleotides in tissue. Voprosy Onkologii 29(4): 67-70

Milcu, S.M.; Potop, I.; Ghinea, E. 1980: Anti-tumor activity of thymosterine. Endocrinologie 18(4): 235-238

Klijn, J.G.; de Jong, F.H.; Blankenstein, M.A.; Docter, R.; Alexieva-Figusch, J.; Blonk-van der Wijst, J.; Lamberts, S.W. 1984: Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer. Breast Cancer Research and Treatment 4(3): 209-220

Chernov, V.A.; Minakova, S.M.; Grushina, A.A. 1968: Anti-tumor and estrogenic activity of derivatives of various hormones with ethylene imido-phosphoric acid residues. Voprosy Onkologii 14(11): 69-75

D'Alessandro, N. 1981: Anti-tumor drugs in renal insufficiency. La Clinica Terapeutica 96(6): 669-675

Tsou, K.C.; Xu, B.; Miller, E.E.; Lo, K.W. 1981: Anti-tumor effect of (S)-10-hydroxycamptothecin on mouse hepatoma BW7756 and its possible mode of action. Anticancer Research 1(2): 115-119

Suzuki, Y.; Tanaka, R. 1980: Anti-tumor effect of ACNU on experimental mouse brain tumors. Neurologia Medico-Chirurgica 20(4): 405-413

Makidono, R.; Matsuura, K.; Makidono, A. 1984: Anti-tumor effect of a streptococcal preparation (OK-432). 1. Positive co-relation between the anti-tumour effect and delayed type hypersensitivity reaction to OK-432 in mice. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 44(2): 379-391

Matsuda, M.; Matsumiya, K.; Tada, Y.; Nakano, E.; Fujioka, H.; Osafune, M.; Takaha, M.; Sonoda, T. 1984: Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside. Hinyokika Kiyo. Acta Urologica Japonica 30(9): 1145-1151

Mori, H.; Nakatomi, I.; Kato, Y.; Koda, A. 1983: Anti-tumor effect of new 5-fluorouracil derivatives and their influences on the immune response. Japanese Journal of Pharmacology 33(6): 1205-1214

Fukushima, M.; Elisabteh, M.; Colmerauer, M.; Nayak, S.K.; Koziol, J.A.; Pilch, Y.H. 1982: Anti-tumor effect of syngeneic spleen cells treated with immune RNA and tumor antigen. International Journal of Cancer 29(1): 113-117

DeWys, W.D.; Hall, T.C. 1973: Anti-tumor effect of the amino acid minosine. European Journal of Cancer 9(4): 281-283

Tominaga, T.; Kitamura, M.; Yoshida, Y.; Kosaki, G. 1984: Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1663-1668

Moscovitch, M.; Slavin, S. 1984: Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW)F1 hybrids with spontaneous lymphosarcoma. Journal of Immunology 132(2): 997-1000

Maier, T.; Levy, J.G. 1982: Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor. Cancer Immunology Immunotherapy: Cii 13(2): 134-139

Sun, Y. 1981: Anti-tumor effects of interferon. Zhonghua Yi Xue Za Zhi 61(9): 556-558

Noguchi, H.; Katsumi, M.; Tabuse, K.; Aoyama, O.; Egawa, H.; Kobayashi, Y.; Nagai, Y.; Yamaue, H. 1983: Anti-tumor effects of microwave coagulation on tumor tissue. Nihon Geka Hokan. Archiv für Japanische Chirurgie 52(4): 520-524

Wakabayashi, S.; Okamoto, S.; Taniguchi, M. 1984: Anti-tumor effects of radiolabeled syngeneic monoclonal anti-melanoma antibodies. Gan 75(8): 707-713

Fink, A.; Shani, A.; Bentwich, Z. 1984: Anti-tumor immunity as measured by the tube leucocyte adherence inhibition assay (ALI). Harefuah 106(2): 86-87

Gordon, J.; Holden, H.T.; Segal, S.; Feldman, M. 1982: Anti-tumor immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors. International Journal of Cancer 29(3): 351-357

Nairn, R.C.; Nind, A.P.; Guli, E.P.; Davies, D.J.; Little, J.H.; Davis, N.C.; Whitehead, R.H. 1972: Anti-tumor immunoreactivity in patients with malignant melanoma. Medical Journal of Australia 1(9): 397-403

Schlag, G.; Redl, H.; Davies, J.; Haller, I. 1994: Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 2(1): 10-18; Discussion: 19-22

Endo, H.; Miyazaki, Y. 1972: Anti-tumor substance in the leaves of Pterocarpus indicus Willd. and P. vidalianus Rolfe. Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 90: 69-71

Bigorgne, J.C.; Rohmer, V.; Mercier, P.; Galland, F. 1982: Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(11): 679-682

Schlesinger, M.; Grossowicz, N.; Lichtenstein, N. 1969: Anti-tumour activity of carbobenzoxy-L-asparagine. Experientia 25(1): 14-15

Uyeki, E.M.; Llacer, V. 1970: Anti-tumour agents on antibody-forming cells in vitro. Biochemical Pharmacology 19(8): 2419-2424

Mourelatos, D.; Dozi-Vassiliades, J.; Granitsas, A. 1982: Anti-tumour alkylating agents act synergistically with methylxanthines on induction of sister-chromatid exchange in human lymphocytes. Mutation Research 104(4-5): 243-247

Mansell, P.W.; Verrier-Jones, J. 1971: Anti-tumour auto-antibody in human malignant melanoma. Journal of Pathology 103(2)

Fray, A.; Moreau, C.; Thobie, N.; Ducluzeau, R. 1982: Anti-tumour cytostatic and cytotoxic properties of peritoneal exudate cells of conventional and germ-free mice, stimulated or not by "Corynebacterium parvum". Annales d'Immunologie 133c(1): 33-43

Svetemoldavsky, G.J.; Kadaghidze, Z.G. 1968: Anti-tumour effect of activated lymphocytes. Lancet 2(7568): 641

Nairn, R.C.; Rollo, A.J.; Nind, A.P.; Rolland, J.M.; Guli, E.P.; Pihl, E.A.; Stevens, D.P. 1974: Anti-tumour immunoreactivity in colonic carcinoma. A guide to early recognition of recurrence. Australian and New Zealand Journal of Medicine 4(6): 531-534

Nicholson, R.I.; Walker, K.J.; Maynard, P.V. 1980: Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICi 118630. European Journal of Cancer Suppl 1: 295-299

Fujii, K. 1993: Anti-type Ii collagen antibodies in rheumatoid arthritis. Ryumachi 33(1): 101-107

Wooley, P.H.; Luthra, H.S.; O'Duffy, J.D.; Bunch, T.W.; Moore, S.B.; Stuart, J.M. 1984: Anti-type Ii collagen antibodies in rheumatoid arthritis. the influence of HLA phenotype. Tissue Antigens 23(5): 263-269

Stickl, H.; Marder, E. 1968: Anti-typhoid vaccination by oral route. Experimental research and clinical and epidemiological results. Revista Clinica Espanola 110(6): 533-536

Buşilă, V.T.; Vasilescu, I.; Vâlceanu, M.; Fitărău, A.; Pintea, L. 1970: Anti-typhoid vaccine prophylaxis and vaccine therapy in carrier states and in typhoid fever. I. Convalescent carriers. Microbiologia Parazitologia Epidemiologia 15(4): 305-311

Barnaulov, O.D.; Denisenko, P.P. 1980: Anti-ulcer action of a decoction of the flowers of the dropwort, Filipendula ulmaria (L.) Maxim. Farmakologiia i Toksikologiia 43(6): 700-705

Wang, B.X.; Liu, A.J.; Cheng, X.J.; Wang, Q.G.; Wei, G.R.; Cui, J.C. 1985: Anti-ulcer action of the polysaccharides isolated from pilose antler. Yao Xue Xue Bao 20(5): 321-325

Lucchetti, G.; Cavallini, L. 1973: Anti-ulcer action of urogastrone. Bollettino Chimico Farmaceutico 112(8): 535-542

Bruseghini, L.; Basi, N.; Gras, J.; Llenas, J.; de Miguel, G.; Rodés, B.; Sanfeliu, C.; Vilageliu, J.; Zapatero, J.; Giraldez, A. 1983: Anti-ulcer activity and other pharmacological properties of lozilurea. Arzneimittel-Forschung 33(12): 1655-1662

Mirzoian, S.A.; Nazaretian, R.A. 1973: Anti-ulcer activity in series of 5-substituted furan-2-carboxylic acids, para-alkoxybenzoic acids and benzofuran polymethylenediamines. Farmakologiia i Toksikologiia 36(3): 306-310

Dammann, H.G.; Walter, T.A.; Müller, P.; Simon, B. 1984: Anti-ulcer agents. Clinico-experimental findings. Die Medizinische Welt 35(7): 233-236

Arcari, G.; Bernardi, L.; Cimaschi, R.; Falconi, G.; Luini, F.; Scarponi, U. 1984: Anti-ulcer and antisecretory activity of selected imidazopiperidines. Arzneimittel-Forschung 34(11): 1467-1471

Leitold, M.; Fleissig, W.; Merk, A. 1984: Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs. Arzneimittel-Forschung 34(4): 468-473

Cavina, E.; Seccia, M.; Pagliai, E.; Rosso, R.; Paganelli, M.; Evangelista, G. 1984: Anti-ulcer drugs and hypergastrinism: utilization in surgery. International Journal of Tissue Reactions 6(2): 195-198

Mirzoian, S.A.; Tatevosian, A.T. 1981: Anti-ulcer effect of gamma-aminobutyric acid and its mechanisms of action. Farmakologiia i Toksikologiia 44(1): 88-91

Wang, Y.T.; Su, C.Y.; Ko, W.C.; Hsu, S.Y.; Tsai, C.S. 1972: Anti-ulcer plants in Taiwan. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 71(4): 256-259

Iukova, B.I. 1965: Anti-ulcer preparation "Plantaglucide". Vrachebnoe Delo 5: 133-134

Dalla Vedova, R.; D'Alò, G.; Cadel, S. 1980: Anti-ulcerogenic activity of sulpiride. a comparative study with cimetidine. Bollettino Chimico Farmaceutico 119(3): 158-163

Ohno, T.; Yamaguchi, Y.; Yajima, T.; Nakamura, K. 1983: Anti-ulcerogenic and cytoprotective effects of trimoprostil (Ro 21-6937), a trimethylprostaglandin E2 derivative. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 82(2): 131-147

Akhtar, A.H.; Ahmad, K.U. 1995: Anti-ulcerogenic evaluation of the methanolic extracts of some indigenous medicinal plants of Pakistan in aspirin-ulcerated rats. Journal of Ethnopharmacology 46(1): 1-6

Samonina, G.E.; Natsvlishvili, N.A.; Ashmarin, I.P. 1994: Anti-ulcerogenic properties of psychostimulants of the phenylalkylsydnone imine series. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 45-46

Sorrentino, F. 1969: Anti-urease immunization in uremic rabbits. Archivio Italiano di Urologia E Nefrologia 42(3): 239-248

Muzyczuk, Z.; Uszyńska-Folejewska, R.; Uszyński, M. 1974: Anti-urokinase activity of the blood serum in pregnant, delivering and postpartum wwomen. Ginekologia Polska 45(1): 51-56

Newman, W.C.; Moon, R.C. 1969: Anti-uterotrophic response of immature mice to 3-methylcholanthrene. Nature 221(5175): 89

Luntz, M.H. 1968: Anti-uveal and anti-lens antibodies in uveitis and their significance. Experimental Eye Research 7(4): 561-569

Hodes, H.L. 1969: Anti-vaccina immunoglobulins in anti-hemophilic globulin. Pediatrics 44(2): 300

Green, D. 1970: Anti-vaccination and syphilis. Medical Journal of Australia 1(10): 500-501

Williamson, S. 1984: Anti-vaccination leagues. Archives of Disease in Childhood 59(12): 1195-1196

Tsunoda, A.; Miyazaki, K.; Aota, T.; Matsumoto, S.; Kumagai, K. 1972: Anti-vaccinia activity of -thiochromanone-1-thiosemicarbazone in vitro and in vivo. Japanese Journal of Microbiology 16(1): 61-66

Herzog, F.; Gaiffe, M.; Badillet, M. 1969: Anti-vaccinia and anti-tetanus gamma globulins made from human plasma. Revue Francaise de Transfusion 12(4): 481-489

Janot, C.; Perrier, P.; Schooneman, F.; Streiff, F.; Stoltz, J.F.; Avenard, G.; Amouch, J.P. 1980: Anti-varicella-zona immunoglobulins. Discovery of antibodies and method of formation. Revue Francaise de Transfusion et Immuno-Hematologie 23(4): 439-448

Dutta, N.K.; Dave, K.H.; Desal, S.M.; Mhasalkar, M.Y. 1968: Anti-variola and anti-vaccinia principles from seeds of Banakadali (Ensete superbum, Cheesm, Musaceae). Indian Journal of Medical Research 56(5): 735-741

Djurić-Milosavljević, O.; Grujic, M.; Zegarac, D. 1972: Anti-variola vaccination in patients with pulmonary tuberculosis in a group previously treated by Pronison and in a group previously protected by gamma globulin. Plucne Bolesti i Tuberkuloza 24(4): 269-275

Cerilli, J.; Jesseph, J.; Miller, A. 1971: Anti-vascular endothelium antibody in renal transplantation. Surgical Forum 22: 241-242

Bodner, A.J.; Cantoni, G.L.; Chiang, P.K. 1981: Anti-viral activity of 3-deazaadenosine and 5'-deoxy-5'-isobutylthio-3-deazaadenosine (3-deaza-SIBA). Biochemical and Biophysical Research Communications 98(2): 476-481

Diwan, A.; Gowdy, C.N.; Robins, R.K.; Prusoff, W.H. 1968: Anti-viral activity of 5,6-dichloro-1-(2'-deoxy-beta-d-ribofuranosyl)benzimidazole and related derivatives. Journal of General Virology 3(3): 393-402

Ingle, V.N. 1968: Pyrexia of unknown origin. Indian Journal of Pediatrics 35(244): 249-250

Imanishi, J. 1980: Anti-viral and anti-neoplastic actions of interferon--with special reference to its clinical application. Nihon Rinsho. Japanese Journal of Clinical Medicine 38(9): 3272-3281

Henderson, F.W. 1981: Anti-viral cytotoxic lymphocyte response in hamsters with parainfluenza virus type 3 infection. Advances in Experimental Medicine and Biology 134: 215-219

Holst-Larsen, L. 1973: Anti-viral drugs. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(16): 1253-1255

Tagov, I. 1970: Anti-viral effect of the ammonium ion on the reproduction of certain viruses of the myxo-group in cell cultures. Izvestiia Na Mikrobiologicheskiia Institut 21: 201-212

Stebbing, N.; Lindley, I.J. 1980: Anti-viral effects of single-stranded polynucleotides against avirulent Semliki Forest virus infection of mice and avirulent infection of rats with encephalomyocarditis virus. Archives of Virology 64(1): 57-66

Zinkernagel, R.M.; Sado, T.; Althage, A.; Kamisaku, H. 1984: Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent. European Journal of Immunology 14(1): 14-23

Li, F.; Tian, T.C.; Shi, Y.C.; Liu, J.Y.; Zhang, S.L.; Zhao, W.; Xiao, C.Y. 1994: Anti-virus effect of aralosides. Zhongguo Zhong Yao Za Zhi 19(9): 562

Motomura, M.; Suenaga, A.; Matsuo, H.; Tsujihata, M.; Nagataki, S. 1994: Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome. Rinsho Shinkeigaku 34(10): 980-984

Satoh, H.; Hayashi, M.; Satoh, S. 1982: Anti-warfarin antibody preparation and its characterization for radioimmunoassay. Journal of Pharmacy and Pharmacology 34(7): 429-433

Forbes, J.I. 1966: Tightness of the skin over the feet and lower limbs associated with haemosiderosis. South African Medical Journal 40(28): 656-660

Ikemi, M. 1972: Anti-womanization and anti-mannequinization - looking for the truth which is able to cope with the appearance. Japanese Journal of Nursing 24(1): 87-90

Cohen, S. 1982: Anti-wrinkle therapy. South African Medical Journal 61(19): 690

Finelli, L. 1963: Anti-yellow fever vaccination. Acta Medica Italica di Medicina Tropicale E Subtropicale E di Gastroenterologia 18(10): 303-311

Rahwan, R.G.; Del Vecchio, F.R.; Azzolin, G.; Witiak, D.T. 1983: Antiabortifacient action of dibenzyloxyindanpropionic acid in mice. Prostaglandins 25(4): 519-530

Groeber, W.R. 1966: Antiabruption dynamics of the intervillous circulation in an artificial uterus. American Journal of Obstetrics and Gynecology 95(5): 640-647

Fromm, G.H.; Glass, J.D.; Chattha, A.S.; Martinez, A.J.; Silverman, M. 1980: Antiabsence drugs and inhibitory pathways. Neurology 30(2): 126-131

Sernka, T.J.; Rood, R.P.; Mah, M.Y.; Tseng, C.H. 1982: Antiabsorptive effects of 16,16 dimethyl prostaglandin E2 in isolated rat colon. Prostaglandins 23(3): 411-426

Arora, S.; Lahiri, P.K. 1968: Antiacetycholine action of imipramine. Japanese Journal of Pharmacology 18(4): 509-513

Zvezdina, N.D.; Kozhukhov, V.I.; Nikulina, L.F.; Prokazova, N.V.; Vaver, V.A. 1974: Antiacetylcholine action of lysolecithin and its diol analogs. Izvestiia Akademii Nauk Sssr. Seriia Biologicheskaia 6: 902-907

Bernardi, M.; Bertolini, A.; Scaltriti, F. 1967: Antiacetylcholine activity in vitro of a parasympatholytic, tridihexyl iodide, and its influence on the neuromuscular block caused by succinylcholine. Bollettino della Societa Italiana di Biologia Sperimentale 43(18): 1202-1205

Inch, T.D.; Brimblecombe, R.W. 1974: Antiacetylcholine drugs: chemistry, stereochemistry, and pharmacology. International Review of Neurobiology 16: 67-144

Fulpius, B.W. 1983: Antiacetylcholine receptor antibodies and myasthenia gravis. International Review of Neurobiology 24: 1-14

Seybold, M.E.; Lindstrom, J.M. 1981: Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis. Neurology 31(6): 778-780

Donaldson, J.O.; Penn, A.S.; Lisak, R.P.; Abramsky, O.; Brenner, T.; Schotland, D.L. 1981: Antiacetylcholine receptor antibody in neonatal myasthenia gravis. American Journal of Diseases of Children 135(3): 222-226

Richter, P.L. 1982: Antiacetylcholine receptor antibody levels and MG. Neurology 32(1): 102

Sen Gupta, A.K.; Srivastava, R.C.; Parmar, S.S. 1966: Antiacetylcholinesterase activity of O,O-diethyl-S-(acetylphenylurea) dithiophosphoric acid esters. Journal of Medicinal Chemistry 9(4): 623

Nanninga, L.B.; Guest, M.M. 1971: Antiactivator (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate. Thrombosis et Diathesis Haemorrhagica 26(3): 541-556

Tsushima, H.; Toki, N. 1981: Antiactivator in plasma of patients with Behçet's disease. Journal of Dermatology 8(5): 379-383

Abraham, S.N.; Hasty, D.L.; Simpson, W.A.; Beachey, E.H. 1983: Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. Journal of Experimental Medicine 158(4): 1114-1128

Bernstein, K.N.; O'Connor, D.T. 1984: Antiadrenergic antihypertensive drugs: their effect on renal function. Annual Review of Pharmacology and Toxicology 24: 105-120

Messerli, F.H.; Dreslinski, G.R.; Husserl, F.E.; Suarez, D.H.; MacPhee, A.A.; Frohlich, E.D. 1981: Antiadrenergic therapy: special aspects in hypertension in the elderly. Hypertension 3(6 Part 2): Ii

Lardy, C.; Rousselot, C.; Chavernac, G.; Depin, J.C.; Guerrier, D. 1994: Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Arzneimittel-Forschung 44(11): 1196-1202

López Pastor, A.; Martínez Ramos, C.; García Muñoz, S.; Gutstein Feldman, D.; Vara Thorbeck, C. 1984: Antiaggregant drugs in traumatic shock lung. Experimental study. Revista Clinica Espanola 173(1): 31-36

Manotti, C.; Potì, R.; Megna, A.; Poli, T.; Alberani, M. 1982: Antiaggregant effect of ticlopidine in atherosclerotic patients. Il Farmaco; Edizione Pratica 37(10): 325-330

Pérez Gómez, F.; Pérez Vizcaíno, F. 1995: Antiaggregants in the prevention of ischemic cardiopathy and systemic thromboembolism. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 14(7-8): 525-531

Cambou, J.P.; Lablache-Combier, B.; Marques-Vidal, P.; Ruidavets, J.B.; Ferrières, J.; Branchu, M.P.; Richard, J.L. 1995: Antiaggregants, aspirin, myocardial infarction and coronary deaths in the Haute-Garonne area. Archives des Maladies du Coeur et des Vaisseaux 88(4): 459-463

Markosian, R.A.; Pozin, E.I.; Popov, E.G.; Rozenshtraukh, L.V. 1983: Antiaggregating action on thrombocytes of a new anti-arrhythmia agent of the phenothiazine series--diethylamine ethmozine analog. Biulleten' Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn SSSR 6(2): 64-66

Kudriashov, S.A.; Geling, N.G.; Mel'nikova, V.I.; Pivnitskiĭ, K.K. 1982: Antiaggregation activity of various synthetic prostaglandins. Biulleten' Eksperimental'noi Biologii i Meditsiny 94(11): 7-9

Swies, J.; Robak, J.; Dabrowski, L.; Duniec, Z.; Michalska, Z.; Gryglewski, R.J. 1984: Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro. Polish Journal of Pharmacology and Pharmacy 36(5): 455-463

Herrmann, K.S. 1984: Antiaggregatory efficacy and its time-course after application of acetylsalicylic acid, prostacyclin and nafazatrom in vivo. Archives Internationales de Pharmacodynamie et de Therapie 272(1): 150-158

Kirstein, P.; Jogestrand, T.; Johnsson, H.; Olsson, A.G. 1980: Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis. Atherosclerosis 36(4): 471-480

Lenkei, R.; Gheţie, V.; Mogoş, A.; Ghyka, P. 1980: Antialbumin agglutinins in HB8Ag-negative hepatic patients. Gastroenterology 79(4): 776-778

Krsiak, M.; Borgesová, M.; Fernandez, S. 1971: Antialcohol effects of some ethanolamine derivatives. Activitas Nervosa Superior 13(3): 198

Shmarov, A.A. 1981: Work in a psychoneurological isolation ward. Fel'dsher i Akusherka 46(2): 55-56

Bogdanovich, L. 1971: Antialcoholic propaganda and sex education. Fel'dsher i Akusherka 36(1): 47-50

Skripchenko, G.A.; Chernyshkova, L.A. 1974: Antialcoholism campaign in Voronezh. Zdravookhranenie Rossiiskoi Federatsii 8: 16-19

Delahaye, J.P.; Lieux, J.M.; Gonin, A. 1966: Antialdosterones and arterial hypertension. Apropos of 32 hypertensive cases treated with an aldactone-derivative-thiazide combination. Lyon Medical 216(38): 477-497

Gonzalez Alvarez, R.; Kazimierczak, W. 1982: Antiallergic action of disodium cromoglycate and xanthone RS 7540. Archivum Immunologiae et Therapiae Experimentalis 30(5-6): 333-339

Lysenko, L.V.; Syla, V.I. 1972: Antiallergic action of peppermint oil azulene. Farmatsevtychnyi Zhurnal 27(6): 65-68

Tajima, S.; Kuroume, T.; Matsumura, T. 1970: Antiallergic action of psychotropic drugs as observed in passive cutaneous anaphylaxis. Arerugi 19(10): 777-787

Chernysheva, L.F.; Kudrin, A.N. 1973: Antiallergic action of sebrin (selenophen 6) in anaphylactic shock in guinea pigs. Farmakologiia i Toksikologiia 36(5): 718-721

Ishii, K.; Yakuo, I.; Seto, Y.; Kita, A.; Nakamura, H.; Nishikawa, Y. 1993: Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals. Arzneimittel-Forschung 43(2): 148-154

Buckle, D.R.; Morgan, N.J.; Ross, J.W.; Smith, H.; Spicer, B.A. 1973: Antiallergic activity of 2-nitroindan-1,3-diones. Journal of Medicinal Chemistry 16(12): 1334-1339

Khandwala, A.; Coutts, S.; Weinryb, I. 1982: Antiallergic activity of tiaramide (RHC 2592-A). International Archives of Allergy and Applied Immunology 69(2): 159-168

Gnabre, J.N.; Halonen, M.J.; Martin, D.G.; Pinnas, J.L. 1994: Antiallergic activity of tylogenin, a novel steroidal compound from Tylophora sylvatica. International Journal of Immunopharmacology 16(8): 641-650

Khandwala, A.; Van Inwegen, R.; Coutts, S.; Dally-Meade, V.; Youssefyeh, R.D. 1983: Antiallergic activity profile in vitro of RHC 2963 and related compounds. International Journal of Immunopharmacology 5(6): 491-502

Honma, Y.; Oda, K.; Hashiyama, T.; Hanamoto, K.; Nakai, H.; Inoue, H.; Ishida, A.; Takeda, M.; Ono, Y.; Tsuzurahara, K. 1983: Antiallergic agents. 2. N-(1H-tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides. Journal of Medicinal Chemistry 26(10): 1499-1504

Honma, Y.; Hanamoto, K.; Hashiyama, T.; Sekine, Y.; Takeda, M.; Ono, Y.; Tsuzurahara, K. 1984: Antiallergic agents. 3. N-(1H-tetrazol-5-yl)-2-pyridinecarboxamides. Journal of Medicinal Chemistry 27(2): 125-128

Doria, G.; Romeo, C.; Corno, M.L.; Cadelli, G. 1980: Antiallergic agents. IV - Substituted 2-benzylidene-3(2H)-benzofuranone-5-carboxylic acids. Il Farmaco; Edizione Scientifica 35(8): 674-680

Davies, R.J.; Moodley, I. 1982: Antiallergic compounds. Pharmacology and Therapeutics 17(3): 279-297

Theoharides, T.C.; Sieghart, W.; Greengard, P.; Douglas, W.W. 1980: Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207(4426): 80-82

Di Mezza, F.; Ninni, A. 1964: Antiallergic drugs in experimental tubercular cavernous processes of the lung. Giornale Italiano di Chemioterapia 11(4): 159-176

Fukuda, T.; Saito, T.; Tajima, S.; Shimohara, K.; Ito, K. 1984: Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413). Arzneimittel-Forschung 34(7): 805-810

Noess, K. 1980: Antiallergic effect of corticosteroids. Action mechanisms. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 100(2): 119-120

Broun, G.R.; Perel'man, A.E. 1970: Antiallergic effect of ethymisol. Biulleten' Eksperimental'noi Biologii i Meditsiny 70(10): 60-63

Klemparskaia, N.N. 1967: Antiallergic effects in radiation lesions. Meditsinskaia Radiologiia 12(4): 78-84

Casey, F.B.; Abboa-Offei, B.E.; Marretta, J. 1980: Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo. Journal of Pharmacology and Experimental Therapeutics 213(3): 432-436

Free, C.A.; Hall, L.E. 1980: Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro. Journal of Pharmacology and Experimental Therapeutics 213(3): 437-440

Agata, M.; Goto, H.; Tsuriya, Y.; Tachibana, K.; Kuroda, T. 1982: Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester. Japanese Journal of Pharmacology 32(4): 689-697

Yevich, J.P.; Temple, D.L.; Covington, R.R.; Owens, D.A.; Seidehamel, R.J.; Dungan, K.W. 1982: Antiallergics: 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-ones. Journal of Medicinal Chemistry 25(7): 864-868

Schwender, C.F.; Sunday, B.R.; Kerbleski, J.J.; Herzig, D.J. 1980: Antiallergy activity of 10-oxo-10-H-pyridazino[6,1-b]quinazoline-2-carboxylic acids. Journal of Medicinal Chemistry 23(8): 964-966

Juby, P.F.; Hudyma, T.W.; Brown, M.; Essery, J.M.; Partyka, R.A. 1982: Antiallergy agents. 2. 2-Phenyl-5-(1H-tetrazol-5-yl)pyrimidin-4(3H)-ones. Journal of Medicinal Chemistry 25(10): 1145-1150

Fabio, P.F.; Lang, S.A.; Lin, Y.I.; Tomcufcik, A.S. 1980: Antiamebic amidines and sulfonamides of 5- and 6-amino-2,3-bis(4-alkyl-1-piperazinyl)quinoxalines. Journal of Medicinal Chemistry 23(2): 201-206

Casinovi, C.G.; Fardella, G.; Grandolini, G.; Burinato, C. 1981: Antiamebic properties of some derivatives of ailantone and quassin. Il Farmaco; Edizione Scientifica 36(2): 116-122

Thompson, P.E.; Bayles, A.; McClay, P.; Meisenhelder, J.E. 1965: Antiamebic studies on 5-chloro-793-diethylaminopropyl-aminomethyl)-8-quinolinol in vitro and in experimentally infected animals. Journal of Parasitology 51(5): 817-822

Elslager, E.F.; Worth, D.F. 1969: Antiamebic, antimalarial, and anthelmintic effects of distal hydrazine analogs of azacrine, quinacrine, and 7-([3-(octylamino)propyl]amino)benz[c]acridine. Journal of Medicinal Chemistry 12(5): 955-957

Shabanov, P.D.; Aleksandrova, I.I. 1984: Antiamnestic properties of pyrazole dicarboxylic acid derivatives in rats. Farmakologiia i Toksikologiia 47(4): 28-30

Biagi, F.; Alvarez, R.; Gonzalez, C. 1974: Antiamoebic action of etophamide in children. Transactions of the Royal Society of Tropical Medicine and Hygiene 68(5): 368-369

Nayar, P.R.; Kumar, A.; Thirumalachar, M.J. 1973: Antiamoebin as feed additive for increased lactation in dairy animals. Hindustan Antibiotics Bulletin 16(2-3): 93-96

Deshmukh, P.V. 1968: Antiamoebin, a new anti-protozoal-anthelmintic antibiotic. II. Chemical characterization. Hindustan Antibiotics Bulletin 10(4): 299-302

Thirumalachar, M.J. 1968: Antiamoebin, a new antiprotozoal-anthelmintic antibiotic. I. Production and biological studies. Hindustan Antibiotics Bulletin 10(4): 287-289

Korkelia, J. 1971: Antianabolic effect of tetracyclines. Lancet 1(7706): 974-975

Rohdewald, M.; Glasmacher, H. 1966: Antianabolistic effect of glucocorticoids. II. Study of rabbit blood. Enzymologia 31(3): 177-183

Tomemori, N.; Shingu, K.; Komatsu, T.; Urabe, N.; Mori, K. 1981: Antianalgesic action of thiamylal sodium in cats. Acta Anaesthesiologica Scandinavica 25(6): 523-525

Frolov, E.P.; Kozlov, V.K.; Men'shikov, V.V.; Bol'shakova, T.D.; Kolesov, D.V.; Lukicheva, T.I. 1969: Antianaphylactic action of proserine in guinea pigs. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 13(1): 80-82

Strigin, V.A.; Ternovoĭ, A.P. 1970: Antianaphylactic activity of fractions obtained by fractionating gamma globulin on Sephadex G-200 gel. Biulleten' Eksperimental'noi Biologii i Meditsiny 70(7): 72-73

Friedberg, K.D.; Garbe, G.; Grützmacher, J. 1969: Antianaphylactic effect of chlorophyllin. Naunyn-Schmiedebergs Archiv für Pharmakologie 265(3): 287-300

Bernauer, W.; Christoffel, R. 1971: Antianaphylactic effect of dexamethasone on guinea pig hearts. Archives Internationales de Pharmacodynamie et de Therapie 191(1): 196-208

Amir, S. 1983: Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla. Brain Research 274(1): 180-183

Renner, H.; Schnitzler, S.; Hagen, V.; Kottke, K.; Kühmstedt, H. 1980: Antianaphylactic effects of 2-hydrazino-3-arylquinazol-4-ones and 4-aryl-5-oxo-4,5-dihydro-s-triazolo[4,3-a]quinazolines. Die Pharmazie 35(12): 801-802

Iso, T.; Uda, K.; Yamauchi, H.; Nakajima, N.; Suda, H. 1980: Antianaphylactic effects of dipivalyl epinephrine and related compounds in rat conjunctiva. Investigative Ophthalmology and Visual Science 19(7): 824-826

Cooper, A.J.; Ismail, A.A.; Phanjoo, A.L.; Love, D.L. 1972: Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. British Journal of Psychiatry: the Journal of Mental Science 120(554): 59-63

Stárka, L.; Bicíková, M.; Hampl, R.; Joska, J.; Fajkos, J. 1984: Antiandrogen activity of 4 beta, 5-cyclopropane-5-beta-androstan -3-ones and their 19-acetoxy derivatives. Ceskoslovenska Farmacie 33(8): 336-339

Reed, M. 1982: Antiandrogen effects of ulcer drug averted with experimental agent. JAMA 248(6): 621-622

Schoonees, R.; Reynoso, G.; De Klerk, J.N.; Murphy, G.P. 1973: Antiandrogen effects on canine prostatic secretion. Investigative Urology 10(6): 434-437

Kaiser, E. 1980: Antiandrogen therapy of acne, falling hair and hirsutism. MMW Munchener Medizinische Wochenschrift 122(26): 975-980

Ritzel, G. 1971: Antiandrogen therapy using cyproteron acetate in child and adolescent psychiatry. a review of prevailing experiences. Praxis der Kinderpsychologie und Kinderpsychiatrie 20(5): 165-169

Laschet, U.; Laschet, L. 1967: Antiandrogen treatment of pathologically increased and abnormal sexuality in men. Klinische Wochenschrift 45(6): 324-325

Abrahamsson, L.; Hackl, H.; Lindström, B.; Martinik, J. 1981: Antiandrogen treatment with cyproterone acetate in with virilizing symptoms. Lakartidningen 78(47): 4259-4261

Akakura, K.; Akimoto, S.; Ohki, T.; Shimazaki, J. 1995: Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate. Urology 45(4): 700

McKinney, G.R.; Braselton, J.P. 1970: Antiandrogenic and antiuterotropic activities of three synthetic progestagens. Steroids 15(3): 405-411

Popper, T.L.; Gardner, J.N.; Neri, R.; Herzog, H.L. 1969: Antiandrogenic and progestational activity of some 17-oxygenated 15-dehydro steroids. Journal of Medicinal Chemistry 12(3): 393-396

Broulik, P.D. 1980: Antiandrogenic effect of cimetidine in mice. Endokrinologie 76(1): 118-121

Ghosh, S.P.; Chatterjee, T.K.; Ghosh, J.J. 1981: Antiandrogenic effect of delta-9-tetrahydrocannabinol in adult castrated rats. Journal of Reproduction and Fertility 62(2): 513-517

Basinger, G.T.; Gittes, R.F. 1974: Antiandrogenic effect of spironolactone in rats. Journal of Urology 111(1): 77-80

Kaur, C.; Mangat, H.K. 1981: Antiandrogenic effects of cyproterone acetate and chloromadinone acetate on the rat hypothalamus as revealed by electroencephalographic responses. Physiologia Bohemoslovaca 30(4): 365-373

Raab, W.P.; Mörth, C. 1973: Antiandrogenic potency of drugs, evaluated by urinary enzyme excretion technique. Experientia 29(6): 687

Messina, M.; Manieri, C.; Biffignandi, P.; Massucchetti, C.; Novi, R.F.; Molinatti, G.M. 1983: Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism. Journal of Endocrinological Investigation 6(1): 23-27

Ablin, R.J.; Burns, G.R.; Guinan, P.; Bush, I.M. 1974: Antiandrogenic suppression of lymphocytic blastogenesis: in vitro and in vivo observations. Experientia 30(11): 1351-1353

Nishimura, R.; Shida, K. 1981: Antiandrogenic therapy for the treatment of early stage prostatic cancer. PROSTATE. Suppl 1: 27-34

Halvorsen, K.A.; Kobbernagel, F.; Kaldan, B. 1972: Antiandrogenic treatment of 2 psychiatric patients. Ugeskrift for Laeger 134(42): 2206-2207

Aron-Brunetière, R.; Dutouquet, C.; Ventura, G. 1984: Antiandrogens and acne. Annales de Dermatologie et de Venereologie 111(3): 249-256

Arzua, E.; Barcena, M.V.; Guimón, J. 1995: Antiandrogens and cholelithiasis. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 87(6): 483-484

Paulson, J.E.; Zelicof, S.; Lynfield, Y. 1995: Antiandrogens for penile surgery. Journal of the American Academy of Dermatology 33(6): 1058-1059

Zabel, J. 1984: Antiandrogens in dermatological therapy. I. Mechanism of action of antiandrogens with special reference to the skin. Przeglad Dermatologiczny 71(3): 291-295

Winkler, K. 1968: Antiandrogens in dermatology. (Gravimetric fatdeterminations during the application of cyproterone). Archiv für Klinische und Experimentelle Dermatologie 233(3): 296-308

Winkler, K. 1972: Antiandrogens in female androgenetic alopecia. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(11): 518-519

Rasmusson, G.H.; Chen, A.; Reynolds, G.F.; Patanelli, D.J.; Patchett, A.A.; Arth, G.E. 1972: Antiandrogens. 2',3' -Tetrahydrofuran-2'spiro-17-(1,2 -methylene-4-androsten-3-ones). Journal of Medicinal Chemistry 15(11): 1165-1168

Zherebtsov, L.A. 1969: Antianemia therapy in cirrhosis of the liver. Vrachebnoe Delo 3: 5-8

Volkmann, B. 1971: Antianemics. 53. Pharmazeutische Praxis 6: 130-133

Reuse, J. 1970: Antiangina medications. Bruxelles Medical 50(9): 553-555

Samek, L.; Roskamm, H. 1982: Antianginal and antiarrhythmic effects of pindolol in post-infarct patients. British Journal of Clinical Pharmacology 13(Suppl 2): 297s

Chopra, B. 1994: Antianginal and cardiopretective effects of terminalia arjuna. Journal of the Association of Physicians of India 42(9): 756

Dwivedi, S.; Agarwal, M.P. 1994: Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. Journal of the Association of Physicians of India 42(4): 287-289

Desiatnichenko, V.M. 1984: Antianginal and hemodynamic effect of propranolol and atenolol in patients with exertion angina. Biulleten' Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn SSSR 7(2): 71-75

Ferlinz, J.; Turbow, M.E. 1980: Antianginal and myocardial metabolic properties of verapamil in coronary artery disease. American Journal of Cardiology 46(6): 1019-1026

Pfisterer, M.; Fridrich, R.; Burkart, F. 1984: Antianginal drug effects on normal, ischemic and scar myocardial segments in man. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 173: 65-73

Ng, R.A. 1981: Antianginal drug therapy (1980). Annals of the Academy of Medicine Singapore 10(4 Suppl): 63-66

Mazurov, A.V.; Leytin, V.L.; Repin, V.S.; Smirnov, V.N.; Taube, C.; Förster, V. 1983: Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates. Thrombosis Research 32(3): 255-266

Aronow, W.S. 1982: Antianginal drugs for stable angina pectoris. Rational Drug Therapy 16(1): 1-7

Rossi, G.V. 1971: Antianginal drugs--a review. American Journal of Pharmacy and the Sciences Supporting Public Health 143(5): 153-160

Fisch, S. 1966: Antianginal drugs. I. the therapeutic role of coronary vasodilators. American Heart Journal 71(2): 281-282

Fisch, S. 1966: Antianginal drugs. II. Human pharmacology of nitroglycerin. American Heart Journal 71(3): 417-419

Fisch, S. 1966: Antianginal drugs. IV. the long-acting nitrates. American Heart Journal 71(5): 712-713

Fisch, S. 1966: Antianginal drugs. Part III. Clinical use of nitroglycerin. American Heart Journal 71(4): 564-565

Fisch, S. 1966: Antianginal drugs. V. Monoamine oxidase (MAO) inhibitors. American Heart Journal 71(6): 837-838

Fisch, S. 1966: Antianginal drugs. VI. Beta-adrenergic blocking agents. American Heart Journal 72(1): 131-133

Fisch, S. 1966: Antianginal drugs. VII. Miscellaneous drugs. American Heart Journal 72(2): 280-281

Lamm, G.; Holló, J. 1968: Antianginal effect of Halidor. Orvosi Hetilap 109(21): 44-45

Hess, O.M.; Krayenbühl, H.P. 1984: Antianginal effect of calcium antagonists, using nisoldipine as an example. Schweizerische Medizinische Wochenschrift 114(33): 1126-1131

Schulz, W.; Kaltenbach, M. 1981: Antianginal effect of nifedipine after intracoronary and intravenous administration judged by reduction of ischemic ST-segment depression in exercise tests. Cardiology 68(Suppl 2): 200-208

Savonitto, S.; Motolese, M.; Agabiti-Rosei, E. 1995: Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. the Italian Multicenter Study. International Journal of Clinical Pharmacology and Therapeutics 33(4): 194-203

Bing, R.J.; Bender, S.R.; Dunn, M.I.; Fry, G.A.; Fuller, W.M.; Liu, S.C.; Miller, H.S.; Moses, J.W.; Ritzmann, L.W.; Segal, J.P.; Shugoll, G.I.; Tillmanns, H.; Wallace, A. 1974: Antianginal effects of chromonar. a combined investigation. Clinical Pharmacology and Therapeutics 16(1): 4-13

Detry, J.M.; Decoster, P.M.; Buy, J.J.; Rousseau, M.F.; Brasseur, L.A. 1984: Antianginal effects of corwin, a new beta-adrenoceptor partial agonist. American Journal of Cardiology 53(4): 439-443

Reichek, N.; Priest, C.; Zimrin, D.; Chandler, T.; Sutton, M.S. 1984: Antianginal effects of nitroglycerin patches. American Journal of Cardiology 54(1): 1-7

Arce-Gomez, E.; Aspe y Rosas, J.; Alcocer Diaz Barreiro, L.; Diaz Barreiro, A.L. 1980: Antianginal effects of pentaerythritol tetranitrate. La Nouvelle Presse Medicale 9(34 Suppl): 2487-2491

Harris, F.J.; Low, R.I.; Paumer, L.; Amsterdam, E.A.; Mason, D.T. 1983: Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease. American Journal of Cardiology 51(1): 13-18

Kenedi, P.; Giebeler, B. 1983: Antianginal efficacy of long-term nitrate therapy. Zeitschrift für Kardiologie 72(Suppl 3): 233-238

White, H.D.; Lowe, J.B. 1983: Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockade. International Journal of Cardiology 3(2): 145-155

Beranek, J.T. 1993: Antiangiogenesis: a suitable preventive treatment of restenosis. Catheterization and Cardiovascular Diagnosis 28(2): 184-186

Dowdle, W.R.; Sarateanu, D.; Reimer, C.B. 1972: Antiantibody enhancement of hemagglutination inhibition by influenza anti-neuraminidase. Journal of Immunology 109(6): 1321-1326

Morris, M.D.; Gebhart, G.F. 1981: Antianxiety agents and emotional behavior, an information processing analysis. Progress in Neuro-Psychopharmacology 5(3): 219-240

Blatt, C.J. 1970: Intrapulmonary sequestration and its diagnosis. Medical Times 98(9): 107-112

McNair, D.M. 1973: Antianxiety drugs and human performance. Archives of General Psychiatry 29(5): 611-617

Anonymous 1972: Antianxiety drugs in organic and functional syndromes. Medical Letter on Drugs and Therapeutics 14(25): 93-94

Cooper, S.a. 1981: Antianxiety, sedative hypnotics. Clinical Preventive Dentistry 3(1): 25-26

Porsolt, R.D.; Roux, S.; Jalfre, M. 1982: Antiapomorphine and locomotor effects of neuroleptics in rhesus monkeys. Pharmacology Biochemistry and Behavior 17(6): 1309-1312

Kaverina, N.V.; Senova, Z.P.; Vikxliàev, I.I.; Ul'iànova, O.V. 1970: Antiarrhythimic properties of ethmozine. Farmakologiia i Toksikologiia 33(6): 693-697

Duc, P. 1995: Antiarrhythmia agents in heart failure. Archives des Maladies du Coeur et des Vaisseaux 88(4 Suppl): 595-598

Jaros, Z. 1970: Antiarrhythmia drugs. Vnitrni Lekarstvi 16(3): 302-303

Nicita-Mauro, V.; Ciraolo, O.; Meduri, N. 1970: Antiarrhythmia effect of lidocaine. Experimental study. Bollettino Della Societa Italiana di Cardiologia 15(2): 116-122

Gupta, S.C.; Sharma, V.N.; Sharma, H.L. 1974: Antiarrhythmic and antiparkinsonian activity of two new promethazine salts. Indian Journal of Experimental Biology 12(6): 504-508

Sharma, P.L. 1972: Antiarrhythmic acitivity of pindolol in adrenaline-evoked ventricular arrhythmias in dogs anaesthetized with halothane in oxygen. British Journal of Anaesthesia 44(12): 1240-1246

Seth, S.D. 1980: Antiarrhythmic action of adrenergic beta-receptor blocking agents. Pharmacology and Therapeutics 11(1): 159-179

Viana, A.P.; Osswald, W. 1971: Antiarrhythmic action of atropine. Archives Internationales de Pharmacodynamie et de Therapie 192(2): 238-246

Somberg, J.C.; Butler, B.; Torres, V.; Flowers, D.; Tepper, D.; Wynn, J.; Keren, G.; Miura, D.S. 1984: Antiarrhythmic action of bethanidine. American Journal of Cardiology 54(3): 343-346

Cartoni, C.; Figini, A.; Carpi, A. 1968: Antiarrhythmic action of certain 1,5-diphenyl-bispidin derivatives. Annali Dell'istituto Superiore di Sanita 4(3): 333-335

Rizzo, A.; Fiorilli, R.; Sisto, F.; Lisanti, P. 1984: Antiarrhythmic action of intravenous mexiletine. Cardiologia 29(3-4): 211-218

Lubbe, W.F.; Nguyen, T.; Edwards, M.F. 1983: Antiarrhythmic action of labetalol and its effect on adenine metabolism in the isolated rat heart. Journal of the American College of Cardiology 1(5): 1296-1301

Barile, C.; Zuccaro, G.M.; Musto, P.; Graziani, M. 1969: Antiarrhythmic action of modern local anesthetics. I. Action on experimental arrhythmias induced with ouabain. Minerva Anestesiologica 35(4): 359-367

Musto, P.; Zuccaro, G.M.; Barile, C.; Orecchia, C. 1969: Antiarrhythmic action of modern local anesthetics. II. Action on experimental arrhythmias induced with adrenaline. Minerva Anestesiologica 35(4): 368-375

Dugin, S.F.; Gorodetskaia, E.A. 1982: Antiarrhythmic action of nitroglycerin on extrasystoles due to the administration of the alpha-adrenomimetic mezaton in unanesthetized cats. Kardiologiia 22(1): 103-105

Levina, T.A.; Romanovskaia, A.I.; Konovalenko, A.V. 1973: Antiarrhythmic action of oxylidin. Kardiologiia 13(4): 142-143

Boissier, J.R.; Coutte, R.; Bertin, M.C.; Giudicelli, J.F. 1974: Antiarrhythmic action of penbutolol. Therapie 29(2): 261-269

Cha, L.; Qian, J.Q.; Lu, F.H. 1981: Antiarrhythmic action of tetrandrine and the total alkaloids of Sophora flavescens. Zhongguo Yao Li Xue Bao 2(1): 26-28

Huang, T.F. 1973: Antiarrhythmic action of tetrodotoxin in various animal species. Japanese Journal of Physiology 23(1): 39-46

Pokorski, M. 1974: Antiarrhythmic action of the anaesthetic drugs. Studies in situ. Acta Physiologica Polonica 25(1): 1-8

Pokorski, M. 1974: Antiarrhythmic action of the anaesthetic drugs. the studies in vitro. Acta Physiologica Polonica 25(1): 9-20

Orlov, V.M.; Kruglov, V.A.; Nikolaevskiĭ, I.R.; Romanenko, I.A.; Fedotenko, S.A. 1982: Antiarrhythmic action of trimecaine in cardiac rhythm disorders. Klinicheskaia Meditsina 60(1): 57-59

Laddu, A.R.; Somani, P. 1969: Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICi 50,172) in the dog heart-lung preparation. Journal of Pharmacology and Experimental Therapeutics 170(1): 79-83

Ahmad, M.; Achari, G. 1969: Antiarrhythmic actions of BC 105. Japanese Journal of Pharmacology 19(1): 19-24

Hanna, C.; Schmid, J.R. 1967: Antiarrhythmic actions of a new coronary vasodilator agent, iproveratril. Journal of the Arkansas Medical Society 63(12): 455

Fagbemi, O.; Parratt, J.R. 1984: Antiarrhythmic actions of adenosine in the early stages of experimental myocardial ischaemia. European Journal of Pharmacology 100(2): 243-244

Anderson, G.J. 1982: Antiarrhythmic actions of amiodarone. American Family Physician 25(4): 178-180

Mendez, R.; Kabela, E.; Pastelin, G.; Martínez-López, M.; Sánchez-Pérez, S. 1969: Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter. Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 262(3): 325-336

Hanna, C.; Schmid, J.R. 1970: Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil. Archives Internationales de Pharmacodynamie et de Therapie 185(2): 228-233

Harrison, D.C.; Collinsworth, K.A. 1974: Antiarrhythmic actions of lidocaine. Annual Review of Medicine 25: 143-148

Lubbe, W.F.; McLean, J.A.; Nguyen, T. 1983: Antiarrhythmic actions of nifedipine in acute myocardial ischemia. American Heart Journal 105(2): 331-333

Baum, T.; Rowles, G.; Shropshire, A.T. 1971: Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366. Journal of Pharmacology and Experimental Therapeutics 176(2): 350-360

Kato, H.; Noguchi, Y.; Takagi, K. 1974: Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers. Japanese Journal of Pharmacology 24(4): 589

Laddu, R. 1970: Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation. European Journal of Pharmacology 9(2): 129-135

Yeager, H.C.; Scriabine, A.; Bellet, S. 1968: Antiarrhythmic activity of Ro-5-5340 in dogs with acute myocardial infarction. Archives Internationales de Pharmacodynamie et de Therapie 175(2): 304-308

Vidrio, H.; Mena, M.A.; Hong, E. 1980: Antiarrhythmic activity of TR 2985, a novel diphenylhydantoin derivative. Arzneimittel-Forschung 30(1): 12-17

Zuccaro, G.M.; Barile, C.; Musto, P.; Graziani, M.; Vergano, F. 1969: Antiarrhythmic activity of a new local anesthetic (F.I. 6655). Minerva Anestesiologica 35(4): 376-382

Nicita-Mauro, V.; Contino, A. 1965: Antiarrhythmic activity of a synthetic antihistaminic (2-phenylbenzylaminomethylimidazoline): clinical contribution. Bollettino Della Societa Italiana di Cardiologia 10(3): 312-320

Wilkerson, R.D.; Henderson, J.D. 1980: Antiarrhythmic activity of amitriptyline analogues in conscious dogs after myocardial infarction: cyproheptadinium methiodide. Journal of Medicinal Chemistry 23(11): 1255-1258

Iur'ev, E.G.; Iur'eva, T.I. 1973: Antiarrhythmic activity of beta-aminoketones in comparison with quinidine and procaine amide in arrhythmia produced by calcium chloride in mice. Farmakologiia i Toksikologiia 36(1): 29-32

Haring, J.; Mesangeau, D.; Huet, Y.; Aurousseau, M. 1980: Antiarrhythmic activity of cetiedil and its analogues. International Journal of Clinical Pharmacology Therapy and Toxicology 18(11): 467-481

Achari, G.; Ahmad, M. 1966: Antiarrhythmic activity of cyproheptadine and methysergide. Indian Heart Journal 18(1): 4-16

Tagieva, Z.D. 1967: Antiarrhythmic activity of dichlorhydrate of N,N1-malonyl-bis-novocaine. Farmakologiia i Toksikologiia 30(4): 428-430

Klein, G.; Wirtzfeld, A.; Alt, E.; Steck, J.; Saunders, R.; Hulse, J.; Kartzinel, R.; Lee, R.; Laddu, A.R. 1984: Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent. International Journal of Clinical Pharmacology Therapy and Toxicology 22(2): 112-117

Shembekar, A.G.; Deshpande, V.R. 1974: Antiarrhythmic activity of ethosuximide and gallamine triethiodide in experimentally induced arrhythmias. Indian Journal of Physiology and Pharmacology 18(4): 330-333

Kozlovský, J.; Cizmárik, J.; Pesák, M.; Inczinger, F.; Borovanský, A. 1982: Antiarrhythmic activity of heptacaine and some of its derivatives. Arzneimittel-Forschung 32(9): 1032-1036

Paradise, R.R. 1967: Antiarrhythmic activity of lidocaine and N-isopropyl-p-nitrophenylethanolamine (INPEA) in acetyl strophanthidin-induced arrhythmias. Archives Internationales de Pharmacodynamie et de Therapie 169(2): 482-493

Lawson, J.W. 1968: Antiarrhythmic activity of some isoquinoline derivatives determined by a rapid screening procedure in the mouse. Journal of Pharmacology and Experimental Therapeutics 160(1): 22-31

Singh, K.P. 1968: Antiarrhythmic activity of ten phenothiazine derivatives and their mode of action. Archives Internationales de Pharmacodynamie et de Therapie 172(2): 475-486

Somani, P. 1969: Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICi 45763). American Heart Journal 77(1): 63-71

Somani, P.; Watson, D.L. 1968: Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999). Journal of Pharmacology and Experimental Therapeutics 164(2): 317-325

Burgess, C.D. 1981: Antiarrhythmic agents V--calcium blockers. Pharmacology and Therapeutics 15(3): 553-565

Köhler, G.D. 1980: Antiarrhythmic agents and agranulocytosis. Lancet 1(8183): 1415-1416

Knippel, M.; Rovelli, F. 1972: Antiarrhythmic agents and atrioventricular conduction. Giornale Italiano di Cardiologia 2(1): 184

Dreifus, L.S.; Morganroth, J. 1980: Antiarrhythmic agents and their use in therapy. Pharmacology and Therapeutics 9(1): 75-106

Coustan, D. 1982: Antiarrhythmic agents during pregnancy. JAMA 247(3): 303

Mauk, W.C. 1971: Applied media. the philosophy and technique. Rehabilitation Record 12(5): 1-5

Mason, D.T.; DeMaria, A.N.; Amsterdam, E.A.; Zelis, R.; Massumi, R.A. 1973: Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology. Drugs 5(4): 261-291

Mason, D.T.; DeMaria, A.N.; Amsterdam, E.A.; Zelis, R.; Massumi, R.A. 1973: Antiarrhythmic agents. II. Therapeutic considerations. Drugs 5(4): 292-317

Adelstein, G.W. 1973: Antiarrhythmic agents. Synthesis and biological activity of some tetrazole and oxadiazole analogs of 4-dialkylamino-2,2-diarylbutyramides. Journal of Medicinal Chemistry 16(4): 309-312

Bonhorst, D. 1995: Antiarrhythmic agents: current situation. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 14(5): 421-429; 362

Hondeghem, L.M.; Katzung, B.G. 1984: Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annual Review of Pharmacology and Toxicology 24: 387-423

Patterson, E.; Lynch, J.J.; Lucchesi, B.R. 1984: Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. Journal of Pharmacology and Experimental Therapeutics 230(2): 519-526

Lynch, J.J.; Wilber, D.J.; Montgomery, D.G.; Hsieh, T.M.; Patterson, E.; Lucchesi, B.R. 1984: Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. Journal of Cardiovascular Pharmacology 6(6): 1132-1141

Kopia, G.A.; Driscoll, E.M.; Yeung, K.F.; Lucchesi, B.R. 1983: Antiarrhythmic and cardiovascular actions of the new antibiotic agent pirlimycin adenylate. Pharmacology 27(5): 255-266

Allen, J.D.; Deering, A.H.; Kelly, J.G.; Shanks, R.G. 1983: Antiarrhythmic and cardiovascular effects of MP 115. Journal of Cardiovascular Pharmacology 5(6): 937-944

Capra, C.; Cristoni, A.; Lietti, A.; Picci, M.; Santi-Soncin, E. 1980: Antiarrhythmic and cardiovascular properties of 17-monochloroacetylajmaline (17-MCAA). Il Farmaco; Edizione Pratica 35(2): 49-70

Coltart, D.J.; Berndt, T.B.; Kernoff, R.; Harrison, D.C. 1974: Antiarrhythmic and circulatory effects of Astra W36095, a new lidocaine-like agent. American Journal of Cardiology 34(1): 35-41

Benditt, D.G.; Benson, D.W.; Dunnigan, A.; Kriett, J.M.; Pritzker, M.R.; Bacaner, M.B. 1984: Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia. American Journal of Cardiology 53(9): 1268-1274

Kvam, D.C.; Banitt, E.H.; Schmid, J.R. 1984: Antiarrhythmic and electrophysiologic actions of flecainide in animal models. American Journal of Cardiology 53(5): 22B-25B

Kniffen, F.J.; Schuster, D.P.; Lucchesi, B.R. 1973: Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart. Journal of Pharmacology and Experimental Therapeutics 187(2): 260-268

Kaplan, H.R.; Barker, J.W.; Dugan, D.; Fox, J.; Giardino, E. 1974: Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol. Archives Internationales de Pharmacodynamie et de Therapie 207(1): 28-43

Ribeiro, L.G.; Brandon, T.A.; Debauche, T.L.; Maroko, P.R.; Miller, R.R. 1981: Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine. American Journal of Cardiology 48(1): 69-74

Sohn, Y.Z.; Hong, J.C.; Katz, R.L. 1982: Antiarrhythmic and hemodynamic responses to adenosine triphosphate during infusion of epinephrine in dogs anesthetized with halothane. Anesthesia and Analgesia 61(5): 423-429

Szekeres, L.; Papp, J.G. 1968: Antiarrhythmic compounds. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 12: 292-369

Grant, A.O.; Starmer, C.F.; Strauss, H.C. 1984: Antiarrhythmic drug action. Blockade of the inward sodium current. Circulation Research 55(4): 427-439

Hondeghem, L.M.; Grant, A.O.; Jensen, R.A. 1974: Antiarrhythmic drug action: selective depression of hypoxic cardiac cells. American Heart Journal 87(5): 602-605

Ross, D.L.; Sze, D.Y.; Keefe, D.L.; Swerdlow, C.D.; Echt, D.S.; Griffin, J.C.; Winkle, R.A.; Mason, J.W. 1982: Antiarrhythmic drug combinations in the treatment of ventricular tachycardia. Circulation 66(6): 1205-1210

Langieri, G.; Marinchak, R.A.; Rials, S.J.; Kowey, P.R. 1995: Antiarrhythmic drug interactions. Current Opinion in Cardiology 10(1): 26-28

Howanitz, J.H.; Howanitz, P.J. 1981: Antiarrhythmic drug monitoring. Clinics in Laboratory Medicine 1(3): 501-522

von Knorre, G.H. 1984: Antiarrhythmic drug therapy and prevention of cardiac emergencies in the prehospital phase. Zeitschrift für Arztliche Fortbildung 78(15): 621-622

Rotmensch, H.H.; Elkayam, U.; Frishman, W. 1983: Antiarrhythmic drug therapy during pregnancy. Annals of Internal Medicine 98(4): 487-497

Jelinek, M.V.; Lohrbauer, L.; Lown, B. 1974: Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias. Circulation 49(4): 659-666

Kienzle, M.G.; Williams, P.D.; Zygmont, D.; Doherty, J.U.; Josephson, M.E. 1984: Antiarrhythmic drug therapy for sustained ventricular tachycardia. Heart and Lung: the Journal of Critical Care 13(6): 614-622

Anonymous 1970: Antiarrhythmic drugs after myocardial infarction. Lancet 1(7649): 707

Artese, D. 1965: Antiarrhythmic drugs and ajmaline (contribution to the clinical use of ajmaline in therapy of cardiac arhythmias). La Riforma Medica 79(44): 1216-1222

Cobb, L.A.; Weaver, W.D. 1984: Antiarrhythmic drugs and cardiac arrest. New England Journal of Medicine 310(17): 1122

Myerburg, R.J.; Castellanos, A. 1983: Antiarrhythmic drugs for the prevention of potentially lethal arrhythmias--assessment of current approaches. International Journal of Cardiology 4(3): 350-356

Farré, J.; Asso, A.; Romero, J.; Cabrera, J.A.; Zayas, R.; Negrete, A.; Fidalgo, M. 1995: Antiarrhythmic drugs in patients with an automatic implantable defibrillator. Pacing and Clinical Electrophysiology: Pace 18(3 Part 2): 579-591

Szmydt, W.; Brodzińska, K.; Luczak, J. 1971: Antiarrhythmic drugs in prevention of recurrent ventricular fibrillation. Polski Tygodnik Lekarski 26(3): 99-101

Harumi, K. 1984: Antiarrhythmic drugs--differences between laboratory and clinical effects. Kokyu to Junkan. Respiration and Circulation 32(12): 1225-1233

Kayden, H.J. 1965: Antiarrhythmic drugs. VI. Clinical use of procaine amide. American Heart Journal 70(4): 567-569

Frieden, J. 1965: Antiarrhythmic drugs. VII. Lidocaine as an antiarrhythmic agent. American Heart Journal 70(5): 713-715

Ruskin, J.N.; McGovern, B.; Garan, H.; DiMarco, J.P.; Kelly, E. 1983: Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. New England Journal of Medicine 309(21): 1302-1306

Bassett, A.L.; Hoffman, B.F. 1971: Antiarrhythmic drugs: electrophysiological actions. Annual Review of Pharmacology 11: 143-170

Ol'binskaia, L.I.; Iurina, M.S.; Litvitskiĭ, P.F.; Sandrikov, V.A. 1980: Antiarrhythmic effect and influence on myocardial contractile function of the preparation, mexitil. Kardiologiia 20(12): 10-13

Weber, H.; Weissel, M.; Haddad, R.; Scheibelhofer, W.; Konrad, K.; Mlczoch, J.; Probst, P.; Mainitz, M. 1984: Antiarrhythmic effect and side effects of amiodarone. Wiener Klinische Wochenschrift 96(18): 685-696

Yoshidomi, M.; Sukamoto, T.; Morita, T.; Ito, K.; Nose, T. 1982: Antiarrhythmic effect of KB-944, a new calcium antagonist. a comparison with verapamil and diltiazem. Arzneimittel-Forschung 32(9): 1056-1059

Moiseev, S.G.; Ustinova, E.Z. 1969: Antiarrhythmic effect of anapryline. Kardiologiia 9(11): 45-47

Ammar, E.M.; Kudrin, A.N. 1969: Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats. Farmakologiia i Toksikologiia 32(5): 566-570

Gorodinskaia, V.Ia. 1969: Antiarrhythmic effect of blocking agent of beta-adrenergic receptors napriline. Farmakologiia i Toksikologiia 32(1): 43-47

Rossano, C.; Romoli, M.; Brunozzi, L.T.; Monti, G.B.; Pavoni, P. 1969: Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia. Acta Anaesthesiologica 20(4): 663-700

Rossano, C.; Romoli, M.; Tini-Brunozzi, L.; Monti, G.B.; Pavoni, P.A.; Collinvitti, G. 1969: Antiarrhythmic effect of butydrin (Recetan) in arrhythmias induced by N-adrenaline in course of methoxyfluorane anesthesia. Experimental research. Acta Anaesthesiologica 20(2): 143-185

Ternova, T.I.; Petrova, S.I.; Ivanov, A.P. 1984: Antiarrhythmic effect of cardiac glycosides in the preclinical stages of heart failure in children with ectopic rhythm disorders. Pediatriia 4: 13-16

Fechter, P.; Nager, F. 1982: Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole. Schweizerische Medizinische Wochenschrift 112(51): 1897-1900

Fossa, A.A.; Carlson, G.P. 1983: Antiarrhythmic effect of disulfiram in various cardiotoxic models. Pharmacology 26(3): 164-171

Giardina, E.G.; Bigger, J.T. 1982: Antiarrhythmic effect of imipramine hydrochloride in patients with ventricular premature complexes without psychological depression. American Journal of Cardiology 50(1): 172-179

Fehér, L.; Kiss, E.; Vágfalvy, I. 1971: Antiarrhythmic effect of iproveratril. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 26(6): 202-204

Horgan, J.H.; Proctor, J.D.; Velandia, J.; Wasserman, A.J. 1973: Antiarrhythmic effect of lithium. Archives Internationales de Pharmacodynamie et de Therapie 206(1): 105-112

Meinertz, T.; Kasper, W.; Kersting, F.; Bechtold, H.; Just, H.; Jähnchen, E. 1980: Antiarrhythmic effect of lorcainide during chronic treatment. Arzneimittel-Forschung 30(9): 1593-1595

Kligfield, P.; Charash, B.; Placek, E.; Sos, T.A. 1981: Antiarrhythmic effect of manganese chloride in infarcted dogs with observations on the dose-related response of heart rate and ventricular pressure. Journal of Pharmacology and Experimental Therapeutics 218(1): 289-295

Samvelian, V.M.; L'vov, V.M.; Dzhampoladian, E.G. 1971: Antiarrhythmic effect of monoethanolamine on myocardial explants of chick embryo in tissue culture. Biulleten' Eksperimental'noi Biologii i Meditsiny 71(6): 56-58

Zaĭtseva, K.A.; Mashkovskiĭ, M.D. 1970: Antiarrhythmic effect of oxylidine. Farmakologiia i Toksikologiia 33(3): 305-309

Ferrero, E.; Manzoni, L. 1972: Antiarrhythmic effect of some local anesthetics. Bollettino Chimico Farmaceutico 111(5): 277-283

Hadházy, P.; Kecskeméti, V.; Vizi, E.S.; Illés, P. 1968: Antiarrhythmic effect of some naphthylalkylamine derivatives. Acta Physiologica Academiae Scientiarum Hungaricae 33(2): 185-195

Smolarz, W.; Kośmider, S. 1969: Antiarrhythmic effect of sviomarin in experimental and clinical glycoside poisoning. Zeitschrift für Kreislaufforschung 58(6): 609-614

Nowak, F.G.; Cocco, G.; Chu, D.; Gasser, D.F. 1980: Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease. Clinical Cardiology 3(6): 371-376

Vrbovský, L. 1971: Antiarrhythmic effect of the diethylaminoethylamide of dehydroabietic acid (substance E-25), quinidine and procaine amide in arrhythmia in anesthetized dogs, induced by K-strophanthin. Bratislavske Lekarske Listy 56(2): 161-179

Dubner, S.; Gimeno, G.; Elencwajg, B.; Quinteiro, R.; Tronge, J.; Bertolasi, C. 1982: Antiarrhythmic effect of tiapamil in patients with acute myocardial infarction. Cardiology 69 Suppl: 172-180

Kaverina, N.V.; Senova, Z.P.; Lyskovzev, V.V.; Demina, L.M.; Grizenko, A.N.; Skoldinov, A.P.; Femmer, K.; Poppe, H.; Stark, A.; Wunderlich, H. 1985: Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines. Die Pharmazie 40(12): 830-832

Schwartz, M.L.; Haider, B.; Covino, B.G.; Co, R.G. 1970: Antiarrhythmic effectiveness of alprenolol, a new beta adrenergic receptor blocking agent. Journal of Electrocardiology 3(3-4): 211-216

Schwartz, M.L.; Meyer, M.B.; Covino, B.G.; Narang, R.M.; Sethi, V.; Schwartz, A.J.; Kamp, P. 1974: Antiarrhythmic effectiveness of intramuscular lidocaine: influence of different injection sites. Journal of Clinical Pharmacology 14(2): 77-83

Sanna, G.; Meoli, P.; Bianchini, C.; Rovelli, F. 1983: Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial. Giornale Italiano di Cardiologia 13(3): 145-151

Smith, E.R.; Duce, B.R.; Boyes, R.N. 1972: Antiarrhythmic effects in dogs of lidocaine administered orally and intravenously. American Heart Journal 83(3): 365-372

Kane, K.; McDonald, F.; Parratt, J.; Timmer, C.; Vink, J. 1982: Antiarrhythmic effects of Org 6001 in rats: correlation with plasma and tissue drug concentrations. British Journal of Pharmacology 75(2): 319-323

Gibala, P.; Kittová, M.; Drímal, J. 1984: Antiarrhythmic effects of VULM 411 in models of experimental arrhythmias. Ceskoslovenska Farmacie 33(10): 425-428

Hombach, V.; Braun, V.; Höpp, H.W.; Gil-Sanchez, D.; Behrenbeck, D.W.; Tauchert, M.; Hilger, H.H. 1981: Antiarrhythmic effects of acute betablockade with atenolol on supraventricular tachycardias at rest and during exercise. Klinische Wochenschrift 59(3): 123-133

Schlesinger, P.; da Rocha, P.J.; Benchimol, A.B. 1981: Antiarrhythmic effects of amiodarone evaluated by dynamic electrocardiography. Arquivos Brasileiros de Cardiologia 37(2): 129-132

Lucchesi, B.R.; Whitsitt, L.S.; Stickney, J.L. 1967: Antiarrhythmic effects of beta adrenergic blocking agents. Annals of the new York Academy of Sciences 139(3): 940-951

Rabkin, S.W.; Ohmae, M.; Klass, D.J. 1982: Antiarrhythmic effects of cyclic guanosine 3' :5'-monophosphate and sodium nitroprusside on barium chloride arrhythmias in rabbits. Archives Internationales de Pharmacodynamie et de Therapie 257(2): 225-238

Hashimoto, K.; Nakayama, K.; Oshima, T.; Kumakura, S. 1971: Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICi 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias. Experientia 27(6): 666-667

Bertoló, L.; Novaković, L.; Penna, M. 1972: Antiarrhythmic effects of droperidol. Anesthesiology 37(5): 529-535

Kinoshita, I.; Itoh, K.; Nishida-Nakai, M.; Hirota, H.; Otsuji, S.; Shibata, N. 1994: Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarction--enhanced cardiac microsomal (Ca(2+)-Mg2+)-ATPase activity. Japanese Circulation Journal 58(12): 903-912

Dangman, K.H.; Hoffman, B.F. 1983: Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering. Journal of Pharmacology and Experimental Therapeutics 227(3): 578-586

Reynolds, R.D.; Calzadilla, S.V. 1980: Antiarrhythmic effects of four different beta-adrenergic blockers in the mouse chloroform arrhythmia model. Research Communications in Chemical Pathology and Pharmacology 29(2): 361-364

Viana, A.P.; Osswald, W. 1970: Antiarrhythmic effects of proadifen hydrochloride (SKF 525-A). Arzneimittel-Forschung 20(6): 851-853

Mentz, P.; Förster, W. 1974: Antiarrhythmic effects of prostaglandin E1, A1 and F2beta against CaCl2- and aconitin-arrhythmias in the rat. Acta Biologica et Medica Germanica 33(2): 245-248

Mentz, P.; Förster, W. 1974: Antiarrhythmic effects of prostaglandins F2alpha, E2, and A2 on CaCl2-and aconitine-arrhythmias. Acta Biologica et Medica Germanica 32(4): 393-402

Wong, K.C.; Wyte, S.R.; Martin, W.E.; Crawford, E.W. 1971: Antiarrhythmic effects of skeletal muscle relaxants. Anesthesiology 34(5): 458-462

Gülker, H.; Bender, F.; Thale, J.; Heuer, H.; Kristek, J.; Hübner, G.; Dorsel, T.; Schmidt, J. 1984: Antiarrhythmic effects of stirocainide in acute myocardial infarction. Arzneimittel-Forschung 34(5): 559-562

Cocco, G.; De Gori, D.; Burkart, F.; Leishman, B. 1982: Antiarrhythmic effects of tiapamil and propranolol assessed from the reduction of ventricular arrhythmias in the cycloergometer test. a double-blind study. Cardiology 69 Suppl: 181-186

Burkart, F.; Baitsch, G.; Braun, S.; Bertel, O.; Cocco, G. 1982: Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease. Cardiology 69 Suppl: 165-171

Aberg, G.; Ronfeld, R.; Aberg, L.; Fitzgerald, T.; McCollom, K.; Moller, R. 1983: Antiarrhythmic effects of tocainide and lidocaine in dogs. Acta Pharmacologica et Toxicologica 53(2): 146-152

Thase, M.E.; Perel, J.M. 1982: Antiarrhythmic effects of tricyclic antidepressants. JAMA 248(4): 429

Wennerblom, B.; Holmberg, S.; Rydén, L.; Wedel, H. 1982: Antiarrhythmic efficacy and side-effects of lidocaine given in the prehospital phase of acute myocardial infarction. European Heart Journal 3(6): 516-524

Rasmussen, K.; Winkle, R.; Ross, D.; Griffin, J.; Peters, F.; Mason, J. 1982: Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings. Acta Medica Scandinavica 212(6): 367-374

Halinen, M.O.; Pentikäinen, P.J.; Helin, M.J.; Rehnberg, S. 1984: Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction. a double blind placebo-controlled study. European Heart Journal 5(8): 675-683

Sami, M.; Harrison, D.C.; Kraemer, H.; Houston, N.; Shimasaki, C.; DeBusk, R.F. 1981: Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment. American Journal of Cardiology 48(1): 147-156

Mason, J.W.; Peters, F.A. 1981: Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia. Circulation 63(3): 670-675

Menozzi, C.; Lolli, G.; Monducci, I.; Gheller, G.; Brignole, M.; Cattabiani, M.L.; Vergoni, W.; Barone, A. 1984: Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects. La Clinica Terapeutica 108(3): 199-208

Klempt, H.W.; Nayebagha, A.; Fabry, E. 1982: Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. a comparative study in patients after myocardial infarction. Zeitschrift für Kardiologie 71(5): 340-349

Klein, M.D.; Levine, P.A.; Ryan, T.J. 1980: Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients. Chest 77(6): 726-730

Roden, D.M.; Reele, S.B.; Higgins, S.B.; Wilkinson, G.R.; Smith, R.F.; Oates, J.A.; Woosley, R.L. 1980: Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. American Journal of Cardiology 46(3): 463-468

Bergey, J.L.; Beil, M.E. 1983: Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs. European Journal of Pharmacology 90(4): 427-431

Bergey, J.L.; McCallum, J.D.; Nocella, K. 1981: Antiarrhythmic evaluation of verapamil, nifedipine, perhexiline and skf 525-A in four canine models of cardiac arrhythmias. European Journal of Pharmacology 70(3): 331-343

Critelli, G. 1983: Antiarrhythmic pacemaker in supraventricular and ventricular hyperkinetic arrhythmias. Giornale Italiano di Cardiologia 13(6): 504-511

Alboni, P.; Masoni, A. 1981: Antiarrhythmic pacemaker. Unsolved problems. Giornale Italiano di Cardiologia 11(8): 1023-1025

Critelli, G.; Grassi, G. 1980: Antiarrhythmic pacemaker: a proposal. Giornale Italiano di Cardiologia 10(11): 1526-1531

Hashimoto, K.; Ishii, M.; Komori, S. 1984: Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias. Journal of Cardiovascular Pharmacology 6(2): 213-219

Nakayama, K.; Koike, H.; Oshima, T.; Hashimoto, K. 1973: Antiarrhythmic potency of N-propyl ajmaline with untoward response of ventricular fibrillation in excess dose. Japanese Journal of Pharmacology 23(1): 9-16

Chodera, A.; Banaszkiewicz, W.; Glinka, B. 1980: Antiarrhythmic properties of Craviten (M-71) in cats and rabbits. Polish Journal of Pharmacology and Pharmacy 32(6): 833-840

Cline, R.E.; Wallace, A.G.; Sealy, W.C.; Young, W.G. 1968: Antiarrhythmic properties of Tris (hydroxymethyl aminomethane). American Journal of Cardiology 21(1): 38-43

Møgelvang, J.C.; Petersen, E.N.; Folke, P.E.; Ovesen, L. 1980: Antiarrhythmic properties of a neuroleptic butyrophenone, melperone, in acute myocardial infarction. a double-blind trial. Acta Medica Scandinavica 208(1-2): 61-64

Corday, E.; Enescu, V.; Vyden, J.K.; Serruya, A.; Lang, T.W.; Carvalho, M. 1971: Antiarrhythmic properties of carbamazepine. Geriatrics 26(10): 78-81

Gillis, R.A.; Thibodeaux, H.; Barr, L. 1974: Antiarrhythmic properties of chlordiazepoxide. Circulation 49(2): 272-282

Galenko-Iaroshevskiĭ, P.A.; Chekanova, O.A.; Skibitskiĭ, V.V.; Bartashevich, V.V.; Khankoeva, A.I.; Poliashova, T.I. 1995: Antiarrhythmic properties of dimebone. Biulleten' Eksperimental'noi Biologii i Meditsiny 119(4): 375-377

Samvelian, V.M.; L'vov, M.V. 1970: Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia. Farmakologiia i Toksikologiia 33(3): 309-313

Kośmider, S.; Smolarz, W.; Rogala, J. 1970: Antiarrhythmic properties of non-ionic detergents in experimental, digitalis-induced arrhythmias. Kardiologia Polska 13(2): 137-141

Brooks, N.; Koch-Weser, J. 1971: Antiarrhythmic prophylaxis in acute myocardial infarction. New England Journal of Medicine 284(15): 852

Koch-Weser, J. 1972: Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease. Archives of Internal Medicine 129(5): 763-772

Koch-Weser, J.; Klein, S.W.; Foo-Canto, L.L.; Kastor, J.A.; DeSanctis, R.W. 1969: Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. New England Journal of Medicine 281(23): 1253-1260

Frick, M.H.; Kala, R. 1981: Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol. American Journal of Cardiology 48(5): 911-916

Ehring, G.R.; Hondeghem, L.M. 1981: Antiarrhythmic structure activity relationships in a series of lidocaine procainamide derivatives. Proceedings of the Western Pharmacology Society 24: 221-224

Gülker, H.; Bender, F.; Brisse, B.; Thale, J.; Heuer, H.; Kristek, J.; Schindelhauer, F.; Teerling, K. 1981: Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction. Zeitschrift für Kardiologie 70(2): 124-130

Woosley, R.L.; Cerskus, I.; Roden, D.M. 1984: Antiarrhythmic therapy: clinical pharmacology update. Journal of Clinical Pharmacology 24(7): 295-305

Ross, W.B.; Mohiuddin, S.M. 1983: Antiarrhythmic therapy: new additions and future expectations. Geriatrics 38(1): 30-35

Kletzkin, M. 1980: Antiarrhythmic therapy: quinidine gluconate vs procainamide. Circulation 61(1): 214-215

Somelofski, C.; Peters, R.W. 1984: Antiarrhythmic therapy: the issue of patient compliance. Annals of the new York Academy of Sciences 432: 286-295

Codecà, L.; Gruppillo, P.; Padovan, G.C.; Masoni, C.; Masoni, A. 1981: Antiarrhythmic treatment with mexiletine in acute myocardial infarction. Giornale Italiano di Cardiologia 11(4): 477-480

Bigger, J.T. 1984: Antiarrhythmic treatment: an overview. American Journal of Cardiology 53(5): 8b

Madan, B.R.; Pendse, V.K. 1970: Antiarrhythmic, anticonvulsant and local anaesthetic activity of cyclizine, chlorcyclizine and homchlorcyclizine. Indian Heart Journal 22(1): 3-10

Saini, R.K.; Antonaccio, M.J. 1982: Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs. Journal of Pharmacology and Experimental Therapeutics 221(1): 29-36

Bacaner, M.B.; Benditt, D.G. 1982: Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias. American Journal of Cardiology 50(4): 728-734

Bergey, J.L.; Sulkowski, T.; Much, D.R.; Wendt, R.L. 1983: Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). Arzneimittel-Forschung 33(9): 1258-1268

Yacone-Morton, L.A. 1995: Antiarrhythmics. Rn 58(4): 26-35; quiz 36

Fulton, B. 1994: Antiarrhythmics in breastfeeding. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 10(3): 193-194

Schmitt, H.; Cheymol, G.; Gilbert, J.C. 1970: Antiarrythmic and hemodynamic effects of imipramine and chlorimipramine. Archives Internationales de Pharmacodynamie et de Therapie 184(1): 158-174

Robertson, S.M.; Clayton, L.; Dev, V.G.; Wall, R.; Capra, J.D.; Kettman, J.R. 1982: Antiarsonate antibody response: a model for studying antibody diversity. Federation Proceedings 41(9): 2502-2506

Zoni, G.; Molinari, M.L.; Banfi, S. 1971: Antiarthritic activity of some anthranilic acid derivatives and their corresponding OH-indazoles. Il Farmaco; Edizione Scientifica 26(3): 191-216

Glenn, E.M.; Rohloff, N. 1972: Antiarthritic and antiinflammatory effects of certain prostaglandins. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 139(1): 290-294

Boussens, J.; Cazaux, R. 1969: Antiarthritic and antivertigo Equilase. Revue de Laryngologie - Otologie - Rhinologie 90(11): 723-732

Floersheim, G.L.; Borel, J.F.; Wiesinger, D.; Brundell, J.; Kis, Z. 1972: Antiarthritic and immunosuppressive effects of Pseudomonas aeruginosa. Agents and Actions 2(5): 231-235

Glenn, E.M.; Lyster, S.C.; Rohloff, N.A. 1971: Antiarthritic effects of the antispermatogenic agent 2,3-dihydro-(1-naphthyl)-4-(1H)-quinazolinone (U-29,409). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 138(1): 244-248

Wright, J.B.; Johnson, H.G. 1973: Antiasthma agents. 1. 4-Oxo-4H-(1) benzothieno-(3,2-b)pyran-2-carboxylic acid and 4-oxo-4H-(1)benzofuro(3,2-b)pyran-2-carboxylic acid. Journal of Medicinal Chemistry 16(7): 861-862

Bence, L.; Dussert, G. 1983: Antiasthma therapy with laser radiation of the stellate ganglia. Minerva Medica 74(27): 1683-1688

Aviado, D.M.; Carrillo, L.R. 1970: Antiasthmatic action of corticosteroids: a review of the literature on their mechanism of action. Journal of Clinical Pharmacology and the Journal of new Drugs 10(1): 3-11

Aviado, D.M. 1970: Antiasthmatic action of sympathomimetics: a review of the literature on their bronchopulmonary effects. Journal of Clinical Pharmacology and the Journal of new Drugs 10(4): 217-221

Protivinsky, R. 1965: Antiasthmatic agents. their effects and side-effects. Therapie der Gegenwart 104(11): 1459-1474

Middleton, E. 1980: Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. Journal of Pharmaceutical Sciences 69(2): 243-251

Cuddy, P.G. 1984: Antiasthmatic drugs. Missouri Medicine 81(11): 715-720

Rebuck, A.S. 1974: Antiasthmatic drugs I: pathophysiological and clinical pharmacological aspects. Drugs 7(5): 344-369

Rebuck, A.S. 1974: Antiasthmatic drugs. II. Therapeutic aspects. Drugs 7(5): 370-390

Fukuda, T.; Saito, T.; Ito, K. 1984: Antiasthmatic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413), a new antiallergic. Arzneimittel-Forschung 34(7): 811-815

Moreno González, A.; Lorenzo Fernández, P. 1971: Antiasthmatic effect of 114 TE. Archivos del Instituto de Farmacologia Experimental 23(1): 109-114

Dorsch, W.; Adam, O.; Weber, J.; Ziegeltrum, T. 1984: Antiasthmatic effects of onion extracts--detection of benzyl- and other isothiocyanates (mustard oils) as antiasthmatic compounds of plant origin. European Journal of Pharmacology 107(1): 17-24

Kumada, S.; Ohara, K.; Motoyama, Y.; Hirai, O.; Tomoi, M. 1981: Antiasthmatic new Japanese molecules: the pharmacological profile of tiaramide hydrochloride. Allergologia et Immunopathologia Suppl 9: 191-199

Salem, H.; Aviado, D.M. 1970: Antiasthmatic preparations containing corticosteroids available in the United States. Review of Allergy 24(9): 819-822

Furkert, K. 1967: Antiasthmatics. 12. Pharmazeutische Praxis 9: 251-253

Protivinski, R. 1965: Antiasthmatics. their action and side effects. Therapie der Gegenwart 104(7): 918-927

Protivinsky, R. 1965: Antiasthmatics. their action and side-effects. 3. Therapie der Gegenwart 104(9): 1161-1178

Protivinsky, R. 1965: Antiasthmatics. their effects and side-effects. Therapie der Gegenwart 104(12): 1586-1595

Orbetzova, V.; Jurukova, Z.; Orbetzova, M. 1980: Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study. Artery 8(6): 560-569

De Buck, R.P. 1974: Antiautistic effect of flupentixol. Acta Psychiatrica Belgica 74(5): 520-525

Alaimo, R.J.; Russell, H.E. 1972: Antibacterial 2,3-dihydro-2-(5-nitro-2-thienyl)-quinazolin-4(1H)-ones. Journal of Medicinal Chemistry 15(3): 335-336

Grier, N.; Dybas, R.A.; Strelitz, R.A.; Witzel, B.E.; Dulaney, E.L. 1982: Antibacterial N-[omega,omega'-bis(alicyclic and aryl)-sec-alkyl]-1,3-diamino-2-propanol dihydrochloride salts. Journal of Pharmaceutical Sciences 71(3): 365-367

Shibata, H. 1981: Antibacterial action against Streptococcus mutans and inhibitory effect on the experimental hamster caries of condensed phosphates. Fukuoka Igaku Zasshi 72(6): 379-391

Galanti, G.; De Petrillo, V.; Carassiti, P. 1971: Antibacterial action in vitro of the association of trimethoprim and sulfamethoxazole on Salmonella typhi and paratyphi. Giornale di Malattie Infettive E Parassitarie 23(1): 38-40

Mitsuhashi, S.; Hashimoto, H.; Fujii, T. 1969: Antibacterial action of Kanamycin and Kanendomycin and genetic aspects of tolerance. Nihon Ishikai Zasshi. Journal of the Japan Medical Association 62(6): 519-524

Fennell, J.F.; Shipman, W.H.; Cole, L.J. 1967: Antibacterial action of a bee venom fraction (melittin) against a penicillin-resistant staphylococcus and other microorganisms. USNRDL-TR-67-101. Research and Development Technical Report. United States. Naval Radiological Defense Laboratory San Francisco 1967: 1-13

Pecherkina, S.A.; Maleeva, L.I.; Shchitsina, I.V. 1982: Antibacterial action of an interferon preparation. its spectrum of action. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 77-79

Divekar, V.M. 1971: Antibacterial action of anaesthetic vapours. British Journal of Anaesthesia 43(2): 207

Bel'tiukova, K.I.; Rotmistrov, M.N.; Kulik, G.V.; Korol'ova, I.B. 1972: Antibacterial action of anilide group substances on phytopathogenic bacteria. Mikrobiolohichnyi Zhurnal 34(4): 525-527

Rowley, D. 1973: Antibacterial action of antibody and complement. Journal of Infectious Diseases 128: Suppl: 170-5

Jackson, S.L. 1972: Antibacterial action of bile. British Medical Journal 4(5835): 300

Obana, Y.; Nishino, T.; Tanino, T. 1983: Antibacterial action of cefoperazone and piperacillin against Escherichia coli. Japanese Journal of Antibiotics 36(2): 249-259

Simmons, N.A. 1969: Antibacterial action of combinations of colistin and the sulphonamides. Journal of Clinical Pathology 22(6): 745

Wooley, R.E.; Gilbert, J.P.; Shotts, E.B. 1982: Antibacterial action of combinations of oxytetracycline, dimethyl sulfoxide, and EDTA-tromethamine on Proteus, Salmonella, and Aeromonas. American Journal of Veterinary Research 43(1): 130-133

Rogala, D.; Kapp-Burzyńska, Z.; Komider, S. 1974: Antibacterial action of complexing compounds. II. Influence of disodium ethylendiaminetetraacetate (NA2EDTA) on experimental infection with Pseudomonas aeruginosa in mice. Archivum Immunologiae et Therapiae Experimentalis 22(6): 791-796

Kośmider, S.; Rogala, D.; Kapp-Burzyńska, Z. 1972: Antibacterial action of complexing compounds. the influence of disodium versenate on microorganisms in vitro. Archivum Immunologiae et Therapiae Experimentalis 20(6): 931-937

Shibata, H.; Morioka, T. 1982: Antibacterial action of condensed phosphates on the bacterium Streptococcus mutans and experimental caries in the hamster. Archives of Oral Biology 27(10): 809-816

Deane, R.S.; Mills, E.L.; Hamel, A.J. 1970: Antibacterial action of copper in respiratory therapy apparatus. Chest 58(4): 373-377

Kobayashi, F.; Tokunaga, M. 1969: Antibacterial action of decamethylenebis-(4-amino-5,6,7,8-tetrahydroquinaldinium) acetate against Escherichia coli. Japanese Journal of Microbiology 13(1): 29-36

Morrier, J.J.; Rocca, J.P.; Barsotti, O. 1995: Antibacterial action of dental cements: an in vitro study. Bulletin du Groupement International Pour la Recherche Scientifique en Stomatologie and Odontologie 38(3-4): 87-93

Evenshteĭn, Z.M. 1969: Antibacterial action of dialuminum pentahydroxychloride in naturally infected river water. Gigiena i Sanitariia 34(8): 75-77

Loew, H.; Prát, V.; Konicková, L.; Hatala, M. 1970: Antibacterial action of erythromycin on experimental E. coli cystitis during alkalinization of the urine in rats. Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 3(4): 378-382

Nagy, J.G.; Tengerdy, R.P. 1968: Antibacterial action of essential oils of Artemisia as an ecological factor. II. Antibacterial action of the volatile oils of Artemisia tridentata (big sagebrush) on bacteria from the rumen of mule deer. Applied Microbiology 16(3): 441-444

Danders, W.; Marahiel, M.A.; Krause, M.; Kosui, N.; Kato, T.; Izumiya, N.; Kleinkauf, H. 1982: Antibacterial action of gramicidin S and tyrocidines in relation to active transport, in vitro transcription, and spore outgrowth. Antimicrobial Agents and ChemoTherapy 22(5): 785-790

Sallai, J.; Papy, L. 1969: Antibacterial action of guanethidine. Acta Pharmaceutica Hungarica 39(3): 123-126

Ulker, N. 1967: Antibacterial action of honey toward different types of Mycobacterium. Turk Tip Cemiyeti Mecmuasi 33(5): 282-287

Carollo, F.; Giammanco, G.; Greco, M.L. 1971: Antibacterial action of human cervical mucus assayed in vitro on cultures of gram-positive and gram-negative bacteria. Bollettino della Societa Italiana di Biologia Sperimentale 47(15): 447-450

Pristupa, M.S. 1972: Antibacterial action of microcide glucose oxidase on the microflora of burn wounds in an experiment. Mikrobiolohichnyi Zhurnal 34(6): 773-777

Ramirez, C. 1969: Antibacterial action of non-volatile substances extracted from Artemisia tridentata Nutt. ssp. tridentata. Canadian Journal of Microbiology 15(11): 1341

Mahmood, F.; Mahmood, N.H.; Holms, W.H. 1980: Antibacterial action of quinolones on Escherichia coli. I. Structure/activity relationship. Zentralblatt für Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie 246(3): 329-335

Wernet, P.; Breu, H.; Knop, J.; Rowley, D. 1971: Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. Journal of Infectious Diseases 124(2): 223-226

Fair, W.R.; Wehner, N. 1971: Antibacterial action of spermine: effect on urinary tract pathogens. Applied Microbiology 21(1): 6-8

Zaikina, N.A.; Iagodkina, M.V.; Solovkiĭ, M.V. 1994: Antibacterial action of the polymeric antiseptic catapol. Antibiotiki i Khimioterapiia 39(4): 48-51

Gallien, R. 1973: Antibacterial action of trimethoprim-sulfamethoxazole. Journal of Infectious Diseases 128(Suppl): 486

Steigbigel, N.H.; McCall, C.E.; Reed, C.W.; Finland, M. 1967: Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Annals of the new York Academy of Sciences 145(2): 224-236

Sy, M.; Pilet, C.; Niel, M.; Maillet, M.; Goret, P. 1965: Antibacterial actions of some halogenated derivatives of m-xylenol. Therapie 20(4): 1071-1077

Meyer, K.; Matz, K.; Utermann, D.; Fedder, J. 1973: Antibacterial active substance concentrations in the aqueous humor in the human following parenteral administration of various antibiotic agents. Albrecht Von Graefes Archiv für Klinische und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology 188(1): 55-70

Budak, A.; Sahl, H.G.; Brandis, H. 1982: Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. 1. Abt. Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie 253(3): 390-396

Kato, M.; Inoue, M.; Mitsuhashi, S. 1982: Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins. Antimicrobial Agents and ChemoTherapy 22(5): 721-727

Kesado, T.; Hashizume, T.; Asahi, Y. 1980: Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrobial Agents and ChemoTherapy 17(6): 912-917

Balischewski, B.; Kiessig, R.; Thal, W.; Köditz, H. 1983: Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children. Kinderarztliche Praxis 51(9): 437-440

Nishimura, T.; Yoshii, S.; Toku, H.; Mochizuki, H. 1973: Antibacterial activities of amidinohydrazones of benzalacetones, cinnamaldehydes, acetophenones and benzaldehydes. Kitasato Archives of Experimental Medicine 46(1): 73-81

Nishimura, T.; Yoshi, S.; Toku, H.; Watanabe, M. 1973: Antibacterial activities of amidinohydrazones. 3. Antibacterial activities of alkoxybenzaldehyde and cinnamaldehyde amidinohydrazones. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 93(9): 1247-1250

Nishimura, T.; Yoshii, S.; Toku, H.; Mochizuki, H. 1973: Antibacterial activities of amidinohydrazones. I. Antibacterial activities of alkoxybenzalacetone amidinohydrazones. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 93(9): 1236-1242

Nishimura, T.; Toku, H.; Yoshi, S.; Morishige, M. 1973: Antibacterial activities of amidinohydrazones. II. Antibacterial activities of alkoxyacetophenone amidinohydrazones. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 93(9): 1242-1246

Shibamoto, S.; Nishimura, T. 1984: Antibacterial activities of amidinohydrazones. VII. Quantitative relationship between structure and antibacterial activities for amidinohydrazones. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 104(11): 1163-1173

Matsuoka, A.; Sumi, K.; Yoshimoto, H.; Takase, M.; Takashima, S.; Mimura, K. 1982: Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials. Japanese Journal of Antibiotics 35(4): 993-1003

Murase, M.; Niiya, T.; Katayama, Y.; Takeuchi, N. 1982: Antibacterial activities of cefotiam against various pathogens isolated from clinical materials. Japanese Journal of Antibiotics 35(4): 1004-1008

Barry, A.L.; Jones, R.N.; Thornsberry, C.; Ayers, L.W.; Gerlach, E.H.; Sommers, H.M. 1984: Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid. Antimicrobial Agents and ChemoTherapy 25(5): 633-637

Acred, P.; Sutherland, R. 1966: Antibacterial activities of combinations of ampicillin and cloxacillin. Antimicrobial Agents and ChemoTherapy 6: 53-58

Ninomiya, K.; Watanabe, K.; Ueno, K.; Suzuki, S.; Mou, I. 1973: Antibacterial activities of lincomycin and clindamycin against anerobic bacteria. Japanese Journal of Antibiotics 26(2): 157-162

Okada, K.; Kawamura, N.; Ohkoshi, M.; Satake, Y.; Kawakita, J. 1982: Antibacterial activities of new cephems against clinically isolated organisms. Japanese Journal of Antibiotics 35(4): 1009-1021

Hof, H.; Zak, O.; Schweizer, E.; Denzler, A. 1984: Antibacterial activities of nitrothiazole derivatives. Journal of Antimicrobial ChemoTherapy 14(1): 31-39

Mengez, A.P.; Miral'ta, T.S.; Serrano, L.L.; Kazanovas, K.S.; Lede Leĭva, K.G.; Zaragoza, A.V. 1967: Antibacterial activity against Mycobacterium tuberculosis of a new tetracycline salt synthesized in Spain and providing a high and constant level of antibiotic in the blood. Antibiotiki 12(8): 663-667

Rosini, S. 1972: Antibacterial activity and absorption of sulphenazone. Acta Paediatrica Academiae Scientiarum Hungaricae 13(3): 221-224

Neu, H.C.; Labthavikul, P. 1982: Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Antimicrobial Agents and ChemoTherapy 21(1): 11-18

Jules, K.; Neu, H.C. 1982: Antibacterial activity and beta-lactamase stability of temocillin. Antimicrobial Agents and ChemoTherapy 22(3): 453-460

Renzini, G.; Ravagnan, G.; Auriti, R.; Bernardi, F. 1969: Antibacterial activity and blood levels of 2 tetracyclines. Antibiotica 7(1): 36-57

Fuglesang, J.E.; Bergan, T. 1983: Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes. Infection 11(6): 329-335

Fuglesang, J.E.; Bergan, T. 1984: Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes. Infection 12(1): 46-50

Atherton, F.R.; Hall, M.J.; Hassall, C.H.; Lambert, R.W.; Lloyd, W.J.; Ringrose, P.S.; Westmacott, D. 1982: Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid. Antimicrobial Agents and ChemoTherapy 22(4): 571-578

Naumann, P.; Reintjens, E. 1974: Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics. Infection 2(1): 19-24

Leigh, D.A. 1981: Antibacterial activity and pharmacokinetics of clindamycin. Journal of Antimicrobial ChemoTherapy 7 Suppl A: 3-9

Ohishi, Y.; Kuriyama, K.; Doi, Y.; Nakanishi, T. 1985: Antibacterial activity and polarographic half-wave reduction potential of 2-nitrobenzo[b]furans. Chemical and Pharmaceutical Bulletin 33(7): 2854-2861

Larsen, B.; Hurry, D.J.; Miro, R.E.; Charles, D. 1983: Antibacterial activity in amniotic fluid from west virginia women. Gynecologic and Obstetric Investigation 15(1): 26-32

Scane, T.M.; Hawkins, D.F. 1984: Antibacterial activity in human amniotic fluid: relationship to zinc and phosphate. British Journal of Obstetrics and Gynaecology 91(4): 342-348

Redin, G.S. 1966: Antibacterial activity in mice of minocycline, a new tetracycline. Antimicrobial Agents and ChemoTherapy 6: 371-376

Tallgren, L.G.; Rusk, J.; Alfthan, O.S.; Johansson, C.J. 1968: Antibacterial activity in semen and its relation to semen quality. Annales Chirurgiae et Gynaecologiae Fenniae 57(4): 540-543

Klastersky, J.; Daneau, D.; Swings, G.; Weerts, D. 1974: Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 129(2): 187-193

Harvey, K.J. 1972: Antibacterial activity in urine. Medical Journal of Australia 1(21): 1072-1074

Ciaffi, G.; Colitti, A.; Renzini, G. 1970: Antibacterial activity in vitro and in vivo and blood levels in man of two antibiotics of the macrolid group: lincomycin and triacetyloleandomycin. Antibiotica 8(2): 206-215

Varone, G.L.; Catalano, G.; Abbate, G.F.; Fici, F. 1972: Antibacterial activity in vitro and in vivo in animals of a combination of 2 semisynthetic penicillins: dicloxacillin and ethacillin. Giornale di Malattie Infettive E Parassitarie 24(4): 231-242

Oliva, B.; Mastrantoni, P.; Nicoletti, M. 1974: Antibacterial activity in vitro and in vivo of a new kanamycin: BBK-8. Antibiotica 12(3-4): 113-133

Adamoli, S. 1965: Antibacterial activity in vitro and in vivo of a new nitrofuran. Minerva Medica 56(99): 4352-4358

Renzini, G.; Ravagnan, G.; Bormioli, P.; D'Alessandro, A. 1969: Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination. Antibiotica 7(4): 250-268

Monnier, J.; Bourse, R. 1968: Antibacterial activity in vitro of a new rifamycin: rifamide. Pathologie et Biologie 16(19): 901-908

Petrini, M.; Cava, L.; Grassi, L. 1968: Antibacterial activity in vitro of cephaloridine. Minerva Medica 59(20): 1093-1108

Oliva, B.; Piccolomini, R.; Nicoletti, M. 1973: Antibacterial activity in vitro of cyclacillin. Antibiotica 11(3-4): 105-110

Nir, M.; Fradis, M.; Cahane, Z.; Wellisch, G.; Podoshin, L. 1983: Antibacterial activity in vitro of ear drops in common use in Israel. Harefuah 104(8): 334-336

Auriti, R.; Ravagnan, L. 1968: Antibacterial activity in vitro of nalidixic acid-neomycin. Antibiotica 6(2): 72-80

Pierangeli, L.; Vellucci, A.; Tallarida, G.; Donati, G. 1964: Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine. Bollettino della Societa Italiana di Biologia Sperimentale 40(24): 1662-1663

Piantieri, G.; Magliulo, E.; Cafarelli, A.; Bossi, G.; Cruciani, M. 1981: Antibacterial activity in vitro of several aminoglycosides and cephalosporins. Giornale di Batteriologia Virologia Ed Immunologia 74(1-6): 77-100

Heindel, N.D.; Ko, C.C.; Birrer, R.B.; Merkel, J.R. 1972: Antibacterial activity of 0-amino-N-hydroxybenzenesulfonamides. Journal of Medicinal Chemistry 15(1): 118-120

Giammanco, G.; Salvo, S.; Falcidia, A.; Marranzano, M.; Sgarlata, G. 1982: Antibacterial activity of 2 trimethoprim analogs (methioprim, brodimoprim) on recently isolated Shigella. Nuovi Annali d'Igiene E Microbiologia 33(2-3): 573-577

Beskid, G.; Eskin, B.; Cleeland, R.; Siebelist, J.; Cappetta, A.; Hill, A.D.; Geiger, R.H. 1981: Antibacterial activity of 2',3'-dideoxyadenosine in vivo and in vitro. Antimicrobial Agents and ChemoTherapy 19(3): 424-428

Tardrew, P.L.; Mao, J.C.; Kenney, D. 1969: Antibacterial activity of 2'-esters of erythromycin. Applied Microbiology 18(2): 159-165

Micetich, R.G.; Raap, R.; Howard, J.; Pushkas, I. 1972: Antibacterial activity of 6-(5-membered heteroarylacetamido)penicillanic acids. Journal of Medicinal Chemistry 15(3): 333-335

Tsukiyama, F.; Katoh, M.; Iida, T.; Nakamura, K.; Watanabe, T.; Ikeda, M.; Muroki, K.; Fujiue, Y.; Kuwabara, M. 1982: Antibacterial activity of 9 antibiotics in relation to serotype and enzyme production of Pseudomonas aeruginosa. Japanese Journal of Antibiotics 35(12): 2805-2811

Massey, E.H.; Kitchell, B.S.; Martin, L.D.; Gerzon, K. 1974: Antibacterial activity of 9(S)-erythromycylamine-aldehyde condensation products. Journal of Medicinal Chemistry 17(1): 105-107

Neu, H.C. 1983: Antibacterial activity of DL 473, a C3-substituted rifamycin derivative. Antimicrobial Agents and ChemoTherapy 24(3): 457-460

Arioli, V.; Berti, M.; Carniti, G.; Randisi, E.; Rossi, E.; Scotti, R. 1981: Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. Journal of Antibiotics 34(8): 1026-1032

Imazato, S.; Russell, R.R.; McCabe, J.F. 1995: Antibacterial activity of MDPB polymer incorporated in dental resin. Journal of Dentistry 23(3): 177-181

Watanabe, T.; Hara, T.; Kasai, T.; Ishii, T.; Miyauchi, K.; Date, H.; Jinzaki, M.; Shindo, H.; Matsugami, A.; Goi, H. 1984: Antibacterial activity of MT-141 against anaerobic bacteria. Japanese Journal of Antibiotics 37(6): 1058-1069

Braveny, I.; Machka, K.; Elsser, R. 1982: Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin. Infection 10(1): 45-49

Grimm, H. 1982: Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains. Arzneimittel-Forschung 32(6): 595-597

Donati, G.; Calabrò, R.; Villanti, P.; Pierangeli, L. 1967: Antibacterial activity of N1-N1-diethyleneaminobiguanide-methyl-tetracycline in combination with other commonly used antibiotics. La Clinica Terapeutica 43(2): 173-176

Hayashi, S.; Yamamoto, S. 1972: Antibacterial activity of Resiguard. Kango Kenkyu. Japanese Journal of Nursing Research 5(3): 314-316

Giamarellou, H.; Poulopoulos, B.; Katsabas, A.; Petrikkos, G.; Papapetropoulou, M.; Daikos, G.K. 1981: Antibacterial activity of Ro 13-9904 and preliminary experience in gonorrhoea and chronic urinary tract infections. ChemoTherapy 27(Suppl 1): 70-74

Chiu, W.C. 1973: Antibacterial therapy in pyelonephritis. Zhonghua Yi Xue Za Zhi 10: 633-636

Pitts, O.M.; Thompson, H.S.; Hoch, J.H. 1969: Antibacterial activity of Solanim carolinense L. Journal of Pharmaceutical Sciences 58(3): 379-380

Sasaki, M.; Yokoyama, T.; Tsunetomi, Y. 1970: Antibacterial activity of Streptococcus faecalis. Igaku to Seibutsugaku. Medicine and Biology 80(1): 7-10

Mulczyk, M. 1983: Antibacterial activity of Wratizolin. Archivum Immunologiae et Therapiae Experimentalis 31(5): 611-613

Hunter, K.W.; Fischer, G.W.; Hemming, V.G.; Wilson, S.R.; Hartzman, R.J.; Woody, J.N. 1982: Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide. Lancet 2(8302): 798-799

Neu, H.C.; Labthavikul, P. 1981: Antibacterial activity of a monocyclic beta-lactam SQ 26,776. Journal of Antimicrobial ChemoTherapy 8 Suppl E: 111-122

Mitsuhashi, S.; Kawabe, H.; Iyobe, S.; Tanaka, T.; Inoue, M. 1974: Antibacterial activity of a new semisynthetic aminoglycoside antibiotic amikacin (BB-K8). Japanese Journal of Antibiotics 27(2): 189-192

Costa, A.L.; Monforte, M.T.; Cusumano, V.; Zamboni, C. 1984: Antibacterial activity of a new synthetic penicillin: sodium sulbenicillin. La Clinica Terapeutica 109(6): 557-561

Bakhtiar, M.; Selwyn, S. 1983: Antibacterial activity of a new thiatetracycline. Journal of Antimicrobial ChemoTherapy 11(3): 291

Kotula, R.; Hudác, A. 1980: Antibacterial activity of a solution of H202, hypochlorite, and chloramine. Ceskoslovenska Stomatologie 80(1): 17-21

Serra, A.; Tringali, G.; Toscano, M.A.; Gismondo, M.R.; Piaia, F. 1980: Antibacterial activity of a sulfonamide combination (Kelfiprim) in some otorhinolaryngological diseases. Giornale di Clinica Medica 61(12): 906-918

Isogai, H.; Kunugi, H.; Nakanishi, M.; Tamaru, S.; Okuda, Y.; Nanba, T.; Katayama, H.; Kitano, S. 1982: Antibacterial activity of aculeacin a against various serotypes of Streptococcus mutans. Josai Shika Daigaku Kiyo. Bulletin of the Josai Dental University 11(1): 15-21

Ovcharenko, O.I.; Teslikova, N.S.; Artemenko, A.I. 1966: Antibacterial activity of alpha-, beta-unsaturated ketones of the furanic sequence. Mikrobiolohichnyi Zhurnal 28(4): 77-79

Tsuchiya, K.; Oishi, T.; Iwagishi, C. 1970: Antibacterial activity of aminocyclohexylpenicillin(AC-PC). Japanese Journal of Antibiotics 23(1): 30-36

Grosser, J. 1974: Antibacterial activity of aminoglycoside antibiotics under reduced oxygen as well as under indreased CO2 pressure. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 228(1): 278-281

Sanfilippo, A.; Mazzoleni, R. 1974: Antibacterial activity of aminosidine and of beta-lactamic antibiotics. Il Farmaco; Edizione Pratica 29(1): 21-26

Neogy, K.N.; Chatterjee, M.L. 1965: Antibacterial activity of ampicillin and cloxacillin. Bulletin of the Calcutta School of Tropical Medicine 13(4): 132-134

Neu, H.C.; Labthavikul, P. 1982: Antibacterial activity of an oral penem, Sch 29482. Journal of Antimicrobial ChemoTherapy 9 Suppl C: 49-57

Coulet, M.; Forey, F.; Brun, Y.; Fleurette, J. 1983: Antibacterial activity of apalcillin against 300 strains of enterobacteria. Pathologie-Biologie 31(5): 311-318

Paradelis, A.G.; Stathopoulos, G.A.; Salpigides, G.N.; Crassaris, L.G. 1983: Antibacterial activity of aztreonam: a synthetic monobactam. a comparative study with thirteen other antibiotics. Methods and Findings in Experimental and Clinical Pharmacology 5(6): 375-383

Täuber, M.G.; Doroshow, C.A.; Hackbarth, C.J.; Rusnak, M.G.; Drake, T.A.; Sande, M.A. 1984: Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. Journal of Infectious Diseases 149(4): 568-574

Parsons, C.L.; Pollen, J.J.; Anwar, H.; Stauffer, C.; Schmidt, J.D. 1980: Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infection and Immunity 27(3): 876-881

Hakak-Berenji, S.N.; Jain, N.C. 1983: Antibacterial activity of bovine blood neutrophils and their cationic proteins. Journal of Dairy Science 66(6): 1377-1383

Chapman, M.A.; Abercrombie, J.; Livermore, D.M.; Williams, N.S. 1995: Antibacterial activity of bowel-cleansing agents: implications of antibacteroides activity of senna. British Journal of Surgery 82(8): 1053

Eykyn, S.; Jenkins, C.; King, A.; Phillips, I. 1973: Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrobial Agents and ChemoTherapy 3(6): 657-661

Imamura, H.; Kobayashi, T.; Murata, K.; Kohbata, S.; Watanabe, I.; Marui, T.; Watanabe, K.; Ninomiya, K.; Ueno, K.; Suzuki, S. 1980: Antibacterial activity of cefoperazone against anaerobic bacteria. Japanese Journal of Antibiotics 33(11): 1171-1182

Minami, S.; Matsubara, N.; Yotsuji, A.; Watanabe, Y.; Yasuda, T.; Saikawa, I.; Mitsuhashi, S. 1983: Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae. Antimicrobial Agents and ChemoTherapy 24(1): 123-125

Mitsuhashi, S.; Inoue, M.; Masuyoshi, S. 1980: Antibacterial activity of cefotaxime. Journal of Antimicrobial ChemoTherapy 6 Suppl A: 37-46

Sawatari, K.; Kitajima, S.; Sotowa, K.; Mochida, C.; Hayashi, A.; Nasu, M. 1981: Antibacterial activity of cefotaxime against main bacteria isolated from clinical samples. Japanese Journal of Antibiotics 34(3): 425-439

Schrinner, E.; Limbert, M.; Penasse, L.; Lutz, A. 1980: Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo). Journal of Antimicrobial ChemoTherapy 6 Suppl A: 25-30

Deguchi, K. 1983: Antibacterial activity of cefotiam against clinical isolates in the field of obstetrics and gynecology. Japanese Journal of Antibiotics 36(4): 678-688

Fu, K.P.; Neu, H.C. 1980: Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin. Antimicrobial Agents and ChemoTherapy 17(4): 583-590

Neu, H.C.; Meropol, N.J.; Fu, K.P. 1981: Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrobial Agents and ChemoTherapy 19(3): 414-423

Dornbusch, K.; Hugo, H.; Lidström, A. 1980: Antibacterial activity of cefuroxime in human bone. Scandinavian Journal of Infectious Diseases 12(1): 49-53

Goto, S.; Kuwabara, S. 1965: Antibacterial activity of cephalothin. Journal of Antibiotics. Ser. B 18(6): 439-442

Goyal, P.; Bhatia, R.; Baveja, U.K.; Agarwal, D.S. 1982: Antibacterial activity of cephamandole--a new antibiotic. Journal of Communicable Diseases 14(2): 130-133

Luh, K.T.; Chao, H.P.; Ho, S.W.; Hsieh, W.C. 1983: Antibacterial activity of cephem antibiotics against common clinical isolates. I. Staphylococcus. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 82(12): 1233-1239

Luh, K.T.; Chao, H.P.; Ho, S.W.; Hsieh, W.C. 1984: Antibacterial activity of cephem antibiotics against common clinical isolates. II. Enterobacteriaceae. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 83(1): 34-44

Luh, K.T.; Chao, H.P.; Ho, S.W.; Hsieh, W.C. 1984: Antibacterial activity of cephem antibiotics against common clinical isolates. III. Pseudomonas aeruginosa. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 83(2): 182-186

Varma, R.S.; Imam, S.A.; Nobles, W.L. 1973: Antibacterial activity of certain 3-substituted benzothiazoline-2-thiones. Journal of Pharmaceutical Sciences 62(1): 140-142

Chatten, L.G.; Myers, G.E.; Khullar, K.K.; Yager, G.A. 1971: Antibacterial activity of certain Mannich bases against Escherichia coli and Staphylococcus aureus. Journal of Pharmaceutical Sciences 60(2): 316-318

Kono, M.; O'Hara, K.; Nagawa, M.; Mitsuhashi, S. 1972: Antibacterial activity of chloramphenicol-related compounds toward a chloramphenicol-resistant strains of Staphylococcus aureus. Japanese Journal of Microbiology 16(6): 461-467

Cavazzini, G.; Bellini, A.M.; Quaglio, M.P.; Guarneri, M. 1982: Antibacterial activity of cholane derivatives. III. Amidie and amine derivatives of cholic, desoxycholic, chenodesoxycholic and ursodesoxycholic acids. Nuovi Annali d'Igiene E Microbiologia 33(2-3): 419-433

Greenwood, D.; Baxter, S.; Cowlishaw, A.; Eley, A.; Slater, G.J. 1984: Antibacterial activity of ciprofloxacin in conventional tests and in a model of bacterial cystitis. European Journal of Clinical Microbiology 3(4): 351-354

Ploy, M.C.; Mounier, M.; Denis, F. 1994: Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae. Pathologie-Biologie 42(5): 379-384

Tokuda, H.; Minatoya, K. 1969: Antibacterial activity of cloxacillin-ampicillin (Viccillin S Meiji) and its effect on ophthalmological infections. Japanese Journal of Antibiotics 22(5): 349-351

Hahn, H.; Kirov, A. 1980: Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro. Arzneimittel-Forschung 30(7): 1047-1048

Barnham, M.; Kerby, J. 1980: Antibacterial activity of combinations of chlorhexidine with neomycin and gentamicin. Journal of Hospital Infection 1(1): 77-81

Bukowska, D. 1972: Antibacterial activity of convalescents' sera following burns. Polski Tygodnik Lekarski 27(14): 513-516

Neu, H.C.; Chin, N.X.; Labthavikul, P. 1984: Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrobial Agents and ChemoTherapy 25(6): 687-689

Neu, H.C. 1982: Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. Reviews of Infectious Diseases 4 Suppl: S374-S378

Carroll, P.T.; Robb, C.A.; Tippett, L.O.; Langston, J.B. 1971: Antibacterial activity of diaveridine, trimethoprim, and selected sulfonamides in prostatic fluid. Investigative Urology 8(6): 686-694

Skotnicki, M.L.; Browne, G.M.; Rogers, P.L. 1984: Antibacterial activity of different Zymomonas mobilis strains. Microbios 39: 157-158

Chylińska, J.B.; Janowiec, M.; Urbański, T. 1971: Antibacterial activity of dihydro-1,3-oxazine derivatives condensed with aromatic rings in positions 5,6. British Journal of Pharmacology 43(3): 649-657

Riolo, U.; Finzi, G.; Pandiani, I.; Ghermandi, D. 1982: Antibacterial activity of disinfectant solutions containing quaternary ammonium compounds for the storage of surgical instruments. Archivio Per le Scienze Mediche 139(4): 491-497

Mikhno, I.L.; Boĭko, L.D.; Taran, V.V.; Alent'ev, A.A.; Sorokopud, L.F. 1981: Antibacterial activity of disposable napkins and impregnating compositions used in their manufacture. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 46-49

Kono, K.; Tatara, I.; Takeda, S.; Arakawa, K.; Hara, Y. 1994: Antibacterial activity of epigallocatechin gallate against methicillin-resistant Staphylococcus aureus. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 68(12): 1518-1522

Mutton, K.J.; Harkness, J.L. 1981: Antibacterial activity of five cephalosporins. Pathology 13(1): 73-77

Thornsberry, C.; Barry, A.L.; Jones, R.N.; Baker, C.N.; Badal, R.E.; Packer, R.R. 1981: Antibacterial activity of fortimicin a compared with those of five other aminoglycosides, and factors affecting susceptibility tests. Antimicrobial Agents and ChemoTherapy 19(1): 122-129

Zemelman, R.; González, C.; Mondaca, M.A. 1980: Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria. Revista Medica de Chile 108(12): 1112-1117

Bianco, M.A.; Gasco, A.; Mortarini, V.; Serafino, A.; Menziani, E. 1973: Antibacterial activity of furoxan and furazane derivatives. Il Farmaco; Edizione Scientifica 28(9): 701-712

Bedniak, A.E.; Pershin, G.N.; Milovanova, S.N. 1967: Antibacterial activity of galbanic acid and of its conversion products. Farmatsiia 16(4): 45-49

Ambrosoli, G.; Ciuti, M.P.; Menozzi, M.G.; Cesari, M. 1969: Antibacterial activity of gentamicin. Giornale Italiano di Chemioterapia 16(1): 11-15

Papapetropoulou, M.; Giamarellou, H.; Papavassiliou, J. 1984: Antibacterial activity of gentamicin in urine and tryptose phosphate broth. Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(2): 97-101

Rudin, A.; Healey, A.; Phillips, C.A.; Gump, D.W.; Forsyth, B.R. 1970: Antibacterial activity of gentamicin sulfate in tissue culture. Applied Microbiology 20(6): 989-990

Moorer, W.R.; Genet, J.M. 1982: Antibacterial activity of gutta-percha cones attributed to the zinc oxide component. Oral Surgery Oral Medicine and Oral Pathology 53(5): 508-517

Bergman, N.; Bercovici, B.; Sacks, T. 1972: Antibacterial activity of human amniotic fluid. American Journal of Obstetrics and Gynecology 114(4): 520-523

Gupta, S.N.; Perkash, I.; Agarwal, S.C.; Anand, S.S. 1967: Antibacterial activity of human prostatic fluid. Investigative Urology 5(3): 219-222

Kaye, D. 1968: Antibacterial activity of human urine. Journal of Clinical Investigation 47(10): 2374-2390

McDonald, M.I.; Graham, I.; Harvey, K.J.; Sinclair, A. 1981: Antibacterial activity of hydrolysed linseed oil and linolenic acid against methicillin-resistant staphylococcus aureus. Lancet 2(8254): 1056

Fosse, T.; Leclercq, R.; Rifai, R.; Toga, B.; Tamalet, C.; Soussy, C.J.; Duval, J. 1984: Antibacterial activity of lamoxactam in combination with penicillin, ampicillin and amoxicillin against clinical strains of Enterococci, group B Streptococci and Listeria. Pathologie-Biologie 32(5): 372-374

Gabka, J. 1968: Antibacterial activity of lincomycin in diseases of the maxillofacial region. Arzneimittel-Forschung 18(11): 1453-1457

Vladimirsky, M.A.; Ladigina, G.A. 1982: Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis. Biomedicine and PharmacoTherapy 36(8-9): 375-377

Ninomiya, K.; Kamiya, H.; Ueno, K.; Suzuki, S.; Ryu, J. 1972: Antibacterial activity of lividomycin against anaerobes. Japanese Journal of Antibiotics 25(6): 356-359

Yamaguchi, M.; Mishashi, S. 1972: Antibacterial activity of lividomycin against several bacteria isolated from clinical specimens. Japanese Journal of Antibiotics 25(6): 336-339

Yamaguchi, M.; Kobayashi, F.; Mitsuhashi, S. 1972: Antibacterial activity of lividomycin toward R factor-resistant strains of Escherichia coli. Antimicrobial Agents and ChemoTherapy 1(2): 139-142

Galbraith, H.; Miller, T.B.; Paton, A.M.; Thompson, J.K. 1971: Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol. Journal of Applied Bacteriology 34(4): 803-813

Valenti, P.; Antonini, G.; Fanelli, M.R.; Orsi, N.; Antonini, E. 1982: Antibacterial activity of matrix-bound ovotransferrin. Antimicrobial Agents and ChemoTherapy 21(5): 840-841

Shimizu, Y. 1981: Antibacterial activity of mecillinam against E. coli isolated from urinary tract infections. Japanese Journal of Antibiotics 34(7): 1087-1091

Saito, T.; Mitsuhashi, S. 1971: Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci. Journal of Antibiotics 24(12): 850-854

Katul, M.J.; Frank, I.N. 1970: Antibacterial activity of methenamine hippurate. Journal of Urology 104(2): 320-324

Izawa, A.; Kisaki, Y.; Irie, K.; Eda, Y.; Nakagome, T.; Komatsu, T. 1980: Antibacterial activity of miloxacin. Antimicrobial Agents and ChemoTherapy 18(1): 37-40

Verbist, L. 1981: Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters. Arzneimittel-Forschung 31(6): 982-986

Callao, V.; Ramos, A. 1966: Antibacterial activity of nalidixic acid (WIN 18320) on various strains of Gram-negative organisms. Microbiologia Espanola 19(2): 173-182

Husemann, B.; Dittrich, H. 1973: Antibacterial activity of nebacetin when administered into the pericardium and mediastinum. Fortschritte der Medizin 91(18): 797-798

Cluzel, M.; Sirot, J.; Chanal, M.; Sirot, D.; Roussanne, M.C. 1982: Antibacterial activity of netilmicin in combination with other antibiotics. Comparison with other aminoglycosides. Pathologie-Biologie 30(6): 376-379

Sasatsu, M.; Kono, M. 1982: Antibacterial activity of netilmicin on cefazolin resistant Staphylococcus aureus. Japanese Journal of Antibiotics 35(9): 2249-2251

Dornbusch, K.; Olsson-Lijequist, B.; Nord, C.E. 1980: Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. Journal of Antimicrobial ChemoTherapy 6(2): 207-216

Glukhov, N.V.; Kulikova, L.K. 1973: Antibacterial activity of new derivatives of nitrofuran and nitrothiophen. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(2): 98-101

McGeachie, J.; Robinson, G.; Black, D. 1972: Antibacterial activity of nifuratel in urine and serum. Journal of Clinical Pathology 25(5): 447-449

Renkonen, O.V. 1983: Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis. Scandinavian Journal of Infectious Diseases. Supplementum 39: 106-108

Powers, L.J.; Mertes, M.P. 1970: Antibacterial activity of nitrobenzofurans. Journal of Medicinal Chemistry 13(6): 1102-1105

Hatala, M.; Hnátek, J.; Liska, M.; Konícková, L.; Uhlír, O.; Prát, V. 1973: Antibacterial activity of nitrooxyquinoline studied in 2 experimental models of pyelonephritis induced by Escherichia coli in rats. Casopis Lekaru Ceskych 112(23): 722-725

Norrby, S.R.; Jonsson, M. 1983: Antibacterial activity of norfloxacin. Antimicrobial Agents and ChemoTherapy 23(1): 15-18

Zerqueni, G.; Rocca Rossetti, S. 1984: Antibacterial activity of norfloxacin and pipemidic acid in a randomized double-blind study. Minerva Urologica e Nefrologica 36(3): 247-251

Frimodt-Møller, P.C.; Jensen, K.M.; Madsen, P.O. 1983: Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats. Antimicrobial Agents and ChemoTherapy 24(4): 560-563

Franceschi, G.; Foglio, M.; Arcamone, F.; Sanfilippo, A.; Schioppacassi, G. 1980: Antibacterial activity of novel broad-spectrum "(5R)-penem" derivatives. Journal of Antibiotics 33(4): 453-454

Podboronov, V.M.; Stepanchenok-Rudnik, G.I.; Grokhovskaia, I.M. 1972: Antibacterial activity of organs and tissues of ticks from the family Ixodoidea. II. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 41(5): 577-581

Yamada, T.; Yamanouchi, T.; Ono, Y.; Nagata, A.; Wakamiya, T.; Teshima, T.; Shiba, T. 1983: Antibacterial activity of palmitoyltuberactinamine N and di-beta-lysylcapreomycin IIA. Journal of Antibiotics 36(12): 1729-1734

Hart, A. 1973: Antibacterial activity of phenylmercuric nitrate in zinc sulphate and adrenaline eye drops B.P.C. 1968. Journal of Pharmacy and Pharmacology 25(6): 507-508

Torosantucci, A.; Cialdea, L.; Calabrò, A.M.; Fillini, G. 1982: Antibacterial activity of pipemidic acid. Annali Dell'istituto Superiore di Sanita 18(3): 467-470

Gupta, K.G.; Gautam, S.C. 1972: Antibacterial activity of polymorphonuclear leucocytes of dog and rabbit. Indian Journal of Experimental Biology 10(1): 46-48

Pershin, G.N.; Shcherbakova, L.I.; Zykova, T.N.; Sokolova, V.N. 1972: Antibacterial activity of pyrimidine and pyrrolo-(3,2-d)-pyrimidine derivatives. Farmakologiia i Toksikologiia 35(4): 466-471

Gillenwater, J.Y.; Cardozo, N.C.; Tyrone, N.O.; Mulholland, S.G.; Hughes, D.G.; Foster, E.A. 1970: Antibacterial activity of rat vesical mucosa. Journal of Urology 104(5): 687-692

Wilson, H.D.; Galloway, C.A.; Roughley, F.R. 1970: Antibacterial activity of resperin vapours. Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 3(1): 61-62

Bertazzoni, E.; Velo, G.P.; Vettori, G.; Berti, T. 1968: Antibacterial activity of rifampicin on faecal flora in rats. Antibiotica 6(3): 125-133

Donati, G.; Pierangeli, L.; Vellucci, A.; Tallarida, G. 1964: Antibacterial activity of ristocetin, kanamycin and farmiglucine in association with other antibiotics. Bollettino della Societa Italiana di Biologia Sperimentale 40(24): 1663-1664

Fiebig, A.; Barteczko, I.; Halkiewicz, A.; Stechnij, I. 1982: Antibacterial activity of silver sulfathiazole in various ointment compositions. Polski Tygodnik Lekarski 37(6): 169-172

Omura, S.; Namiki, S.; Shibata, M.; Muro, T.; Machida, S. 1971: Antibacterial activity of some acetyl derivatives of kujimycin a. Journal of Antibiotics 24(10): 717-718

Coutts, R.T.; Pitkethly, W.N.; Wibberley, D.G. 1965: Antibacterial activity of some quinolines containing a cyclic hydroxamic acid group. Journal of Pharmaceutical Sciences 54(5): 792-795

Virtanen, S. 1974: Antibacterial activity of sulphamethoxazole and trimethoprim under diminished oxygen tension. Journal of General Microbiology 84(1): 145-148

Parker, R.H.; Schmid, F.R. 1971: Antibacterial activity of synovial fluid during therapy of septic arthritis. Arthritis and Rheumatism 14(1): 96-104

Peters, G.; Pulverer, G. 1983: Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin. Journal of Antimicrobial ChemoTherapy 11(1): 94-95

Pulverer, G.; Peters, G. 1982: Antibacterial activity of temocillin (BRL 17421), a new semisynthetic penicillin. Journal of Antimicrobial ChemoTherapy 9(5): 412-413

Ravagnan, G.; Oliva, B.; Bevilacqua, R. 1974: Antibacterial activity of the association of 5,7-dichloro-8-hydroxyquinoline and 5,7-dichloro-8-hydroxyquinaldine with enzymes and bile. Il Farmaco; Edizione Pratica 29(4): 198-204

Clarke, A.M.; Zemcov, S.J. 1983: Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics. Journal of Antimicrobial ChemoTherapy 11 Suppl: 67-72

Klastersky, J.; Daneau, D.; Van Moer, N. 1972: Antibacterial activity of the combination ampicillin-kanamycin against gram-negative bacteria. Pathologie-Biologie 20(9): 443-448

Krüger, E.; Machka, K.; Braveny, I. 1983: Antibacterial activity of the combination of cefoperazone piperacillin. Arzneimittel-Forschung 33(4): 571-574

Böhni, E. 1969: Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics. Schweizerische Medizinische Wochenschrift 99(42): 1505-1510

Girard, J.P.; de Kalbermatten, A. 1970: Antibacterial activity of the human duodenal juice in the presence of specific antibodies. Helvetica Medica Acta. Supplementum 1970: Suppl 50: 115-116

Reeves, D.S.; Bywater, M.J.; Holt, H.A. 1981: Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp. Journal of Antimicrobial ChemoTherapy 8 Suppl E: 57-68

Sulejmanagić, H.; Kućanski, B.; Gojkov, T. 1981: Antibacterial activity of the tissue adhesive N-butyl-2-cyanoacrylate-monomer. Stomatoloski Vjesnik. Stomatological Review 10(1-2): 37-40

Acar, J.F. 1974: Antibacterial activity of tobramycin. La Nouvelle Presse Medicale 3: 57-59

Fleurette, J.; Flandrois, J.P. 1974: Antibacterial activity of tobramycin on Pseudomonas aeruginosa. La Nouvelle Presse Medicale 3: 40-42

Witchitz, J. 1974: Antibacterial activity of tobramycin on enterobacteria. Present aspects of resistance factors. La Nouvelle Presse Medicale 3: 43-46

Jouvenaz, D.P.; Blum, M.S.; MacCONNELL, J.G. 1972: Antibacterial activity of venom alkaloids from the imported fire ant, Solenopsis invicta Buren. Antimicrobial Agents and ChemoTherapy 2(4): 291-293

López Abraham, A.M.; Rojas Hernández, N.M. 1984: Antibacterial activity of yeasts of the genus Candida. I. Preliminary report. Revista Cubana de Medicina Tropical 36(2): 174-186

Miski, M.; Ulubelen, A.; Johansson, C.; Mabry, T.J. 1983: Antibacterial activity studies of flavonoids from Salvia palaestina. Journal of Natural Products 46(6): 874-875

Brogard, J.M.; Kuntzmann, F.; Lavillaureix, J. 1974: Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile. Arzneimittel-Forschung 24(9b): 1528-1533

Anonymous 1966: Antibacterial agents and cell regeneration in the intestine. Nutrition Reviews 24(2): 60-62

Papastamelos, A.G.; Tunkel, A.R. 1995: Antibacterial agents in infections of the central nervous system and eye. Infectious Disease Clinics of North America 9(3): 615-637

Korzeniowski, O.M. 1995: Antibacterial agents in pregnancy. Infectious Disease Clinics of North America 9(3): 639-651

Anonymous 1971: Antibacterial agents in renal failure. British Medical Journal 1(5750): 621-622

Ziment, I. 1969: Antibacterial agents in renal insufficiency. California Medicine 111(5): 377-382

Midtvedt, T. 1972: Antibacterial agents. 1. Penicillins. 1. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(31): 2099-2101

Kreutzberger, A.; Tantawy, A.; Stratmann, J. 1985: Antibacterial agents. 10. 2-(Methylthioanilino)pyrimidines. Archiv der Pharmazie 318(11): 1043-1045

Holst-Larsen, L. 1972: Antibacterial agents. 4. Erythromycin. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(35): 2446-2447

Bergan, T. 1973: Antibacterial agents. 5. Gentamycin. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(1): 34-36

Holst-Larsen, L. 1973: Antibacterial agents. 6. Lincomycin and clindamycin. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(6): 398-399

Kreutzberger, A.; Tantawy, A. 1981: Antibacterial agents. 7. Aminomethinylation of guanidino heterocycles. Archiv der Pharmazie 314(11): 968-969

Berdal, B.P. 1973: Antibacterial agents. 7. Streptomycin. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(7): 463-464

De Biase, S.; De Grandis, E. 1973: Antibacterial and anti-inflammatory drugs in the treatment of dystrophic periodontitis. Annali di Stomatologia 22(1): 17-30

Smirnov, B.N. 1969: Antibacterial and antiendotoxic properties of leukocytes in postinfectious immunity to paratyphoid infection. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 13(2): 48-50

Elnima, E.I.; Zubair, M.U.; Al-Badr, A.A. 1981: Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives. Antimicrobial Agents and ChemoTherapy 19(1): 29-32

Hufford, C.D.; Sharma, A.S.; Oguntimein, B.O. 1980: Antibacterial and antifungal activity of liriodenine and related oxoaporphine alkaloids. Journal of Pharmaceutical Sciences 69(10): 1180-1183

Carlone, N.; Carpi, C. 1971: Antibacterial and antifungal effect of pyrrolnitrine. Giornale di Batteriologia Virologia Ed Immunologia Ed Annali Dell'ospedale Maria Vittoria di Torino 64(9): 377-391

Willers, D.; Lehmann-Danzinger, H.; Führer, E. 1982: Antibacterial and antimycotic effect of a newly discovered secretion from larvae of an endoparasitic insect, Pimpla turionellae L. (hym.). Archives of Microbiology 133(3): 225-229

Majumdar, A.S.; Dutta, P.; Dutta, D.; Ghose, A.C. 1981: Antibacterial and antitoxin responses in the serum and milk of cholera patients. Infection and Immunity 32(1): 1-8

Ashmarin, I.P.; Zhdan-Pushkina, S.M.; Kokriakov, V.I.; Samedov, A.S.; Antonova, S.N. 1972: Antibacterial and antiviral functions of basic cell proteins and the prospects for their practical application. Izvestiia Akademii Nauk Sssr. Seriia Biologicheskaia 4: 502-508

Pase, U.; Travaglini, A. 1967: Antibacterial and bacteriostatic activity of carbol resin and sandarac resins. Il Friuli Medico 22(2): 453-457

Tishchenko, E.I.; Denisenko, V.P.; Odinak, I.M. 1969: Antibacterial and fungicidal properties of a biquaternary ammonium salt derivative of dekamethylene diamine. Vestnik Dermatologii i Venerologii 43(11): 42-45

Zapopozhets, T.S.; Besednova, N.N.; Loenko, I.N. 1995: Antibacterial and immunomodulating activity of fucoidan. Antibiotiki i Khimioterapiia 40(2): 9-13

Sil'vestrov, V.P.; Karaulov, A.V. 1983: Antibacterial and immunomodulating therapy of respiratory tract diseases. Terapevticheskii Arkhiv 55(3): 3-9

Jedrychowski, J.R.; Caputo, A.A.; Kerper, S. 1983: Antibacterial and mechanical properties of restorative materials combined with chlorhexidines. Journal of Oral Rehabilitation 10(5): 373-381

Kramer, S.J.; Spadaro, J.A.; Webster, D.A. 1981: Antibacterial and osteoinductive properties of demineralized bone matrix treated with silver. Clinical Orthopaedics and Related Research 161: 154-162

Pryknod'ko, V.S.; Odynets', I.V.; Bezkorovaĭna, O.I.; Shovkoplias, I.A.; Iablons'ka, N.N. 1980: Antibacterial and pathogenetic therapy of acute respiratory viral infections, viral pneumonias and viral diarrheas in children. Pediatriia Akusherstvo i Ginekologiia 2: 11-14

Dormia Cristallo, L.; De Pascale, V. 1969: Antibacterial and pharmacokinetic aspects of naphthyridine derivatives. Bollettino Chimico Farmaceutico 108(6): 377-389

Gutierrez Millet, V.; Soriano Garcia, F.; Alés Reinlein, J.M.; Hernando Avendaño, L. 1974: Antibacterial antiboby levels in urinary tract infections. Biomedicine / 21(3): 110-113

Monteiro, E.; Fossey, J.; Shiner, M.; Drasar, B.S.; Allison, A.C. 1971: Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet 1(7693): 249-250

Salazar Mallén, M.; Amezcua Chavarría, M.E.; Rivas Pástor, E.S. 1970: Antibacterial behavior of leukocytes in normal subjects and in patients with Chediak-Higashi or Pelger-Huet anomaly. Revista de Investigacion en Salud Publica 30(1): 5-16

Gronowitz, S.; Dahlgren, T.; Namtvedt, J.; Roos, C.; Sjöberg, B.; Forsgren, U. 1971: Antibacterial borazaro derivatives. I. 5-Arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines. Acta Pharmaceutica Suecica 8(4): 377-390

Gronowitz, S.; Dahlgren, T.; Namtvedt, J.; Roos, C.; Rosén, G.; Sjöberg, B.; Forsgren, U. 1971: Antibacterial borazaro derivatives. II. Effect of substituents on the antibacterial activity of 5-arylsulphonyl-4-hydroxy-4,5-borazarothieno(2,3-c)pyridines and 6-arylsulphonyl-7-hydroxy-7,6-borazarothieno(3,2-c)pyridines. Acta Pharmaceutica Suecica 8(6): 623-638

Morgenroth, H. 1974: Antibacterial chemical prevention and therapy in thoracic and vascular surgery. Comment to M. Eide, G. Koch: Med. Klin. 68 (1973), 742. Medizinische Klinik 69(19): 863

Eide, M.; Koch, G. 1974: Antibacterial chemical prevention and therapy in thoracic and vascular surgery. Summary. Medizinische Klinik 69(19): 864

Herrmann, E. 1973: Antibacterial chemoprevention and antibiotic therapy in surgical orthopedics. Zeitschrift für Orthopadie und ihre Grenzgebiete 111(1): 47-52

Eide, M.; Koch, G. 1973: Antibacterial chemoprevention and therapy in thoracic and vascular surgery. Medizinische Klinik 68(22): 742-745

Krämer, J.; Weuta, H. 1970: Antibacterial chemoprophylaxis in surgical orthopedics. Zeitschrift für Orthopadie und ihre Grenzgebiete 108(1): 130-138

Vuga, D. 1966: Antibacterial chemoprophylaxis of chronic bronchitis. La Clinica Terapeutica 37(3): 272-276

Drews, J. 1972: Antibacterial chemotherapy. Deutsches Medizinisches Journal 23(7): 459-460

Zazgornik, J. 1983: Antibacterial chemotherapy in impaired renal function. Wiener Klinische Wochenschrift. Supplementum 142: 15-17

Briedigkeit, H. 1983: Antibacterial chemotherapy in renal failure. Zeitschrift für Urologie und Nephrologie 76(5): 349-352

Whelton, A. 1974: Antibacterial chemotherapy in renal insufficiency. a review. Antibiotics and ChemoTherapy 18: 1-48

Bellucci, G.; Stanca, A.; Penza, B.; Laurini, G.P.; Bianciardi, P.; De Alexandris, M. 1981: Antibacterial chemotherapy in resuscitation. Our clinical experience. Minerva Anestesiologica 47(11): 741-751

Govorovich, E.A.; Marshak, A.M. 1969: Antibacterial chemotherapy in the complex treatment of cholecystitis. Khirurgiia 45(3): 61-65

Klaschka, F.; Rudolph, R. 1981: Trogoderma angustum Solier larva - a new inhaled allergen. Dermatosen in Beruf und Umwelt. Occupation and Environment 29(1): 9-11

Trendelenburg, F. 1972: Antibacterial chemotherapy of bronchopulmonary infections. Deutsches Medizinisches Journal 23(7): 469-472

Tauchnitz, C.; Ellorhaoui, M. 1974: Antibacterial chemotherapy of the chronic bronchitis syndrome. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(3): 97-104

Miller, A.K.; Kropp, H. 1966: Antibacterial chemotherapy tests. II. Influence of route and number of treatments on in vivo effectiveness of streptomycin and tetracycline and influence on resistance to rechallenge. Antimicrobial Agents and ChemoTherapy 6: 377-381

Harris, D.M. 1966: Antibacterial chemotherapy: a bacteriologist's approach to clinical problems. Guy's Hospital Reports 115(2): 159-174

Grimm, H.; Fell, J.J. 1980: Antibacterial comparison of sulfonamide combinations. Medizinische Klinik 75(20): 726-727

Wang, H.L.; Ruttle, D.I.; Hesseltine, C.W. 1969: Antibacterial compound from a soybean product fermented by Rhizopus oligosporus. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 131(2): 579-583

Dunn, B.L.; Stamey, T.A. 1967: Antibacterial concentrations in prostatic fluid. 1. Nitrofurantoin. Journal of Urology 97(3): 505-507

Wagner, W.; Weuta, H.; Tetsch, P.; Förster, D. 1983: Antibacterial concentrations in serum and tooth-jawbone tissue following perioperative administration of propicillin. Infection 11(6): 336-339

Annunziata, A.; Martina, I.; Panetti, L. 1968: Antibacterial concentrations in the blood, saliva and tonsils in dogs treated with sodium fusidate. Archivii Italiani di Laringologia 1968(Suppl): 83-86

Findlay, J.A.; Patil, A.D. 1984: Antibacterial constituents of the diatom Navicula delognei. Journal of Natural Products 47(5): 815-818

Miller, H.; Phillips, E. 1970: Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde. Investigative Urology 8(1): 21-33

Hahn, H. 1983: Antibacterial defence mechanisms. Infection 11 Suppl. 2: S112-S118

Orikasa, S. 1980: Antibacterial defense mechanism of the urinary tract. Hokkaido Journal of Medical Science 55(4): 291-295

Wysocki, S. 1972: Antibacterial drug therapy in surgery. Deutsches Medizinisches Journal 23(4): 296-300

Kreutzberger, A.; Leger, M. 1982: Antibacterial drugs VI: 2,4-Unsymmetrically dialkylated pyrimido[1,2-a]benzimidazoles. Archiv der Pharmazie 315(1): 47-52

Kroon, A.M.; Van den Bogert, C. 1983: Antibacterial drugs and their interference with the biogenesis of mitochondria in animal and human cells. Pharmaceutisch Weekblad. Scientific Edition 5(3): 81-87

Speirs, C.F.; Stephen, K.W. 1968: Antibacterial drugs for oral infections. British Dental Journal 125(4): 158-162

Kudinova, T.I.; Ekisenina, N.I.; Chanisheva, R.I.; Furosova, G.A. 1972: Antibacterial drugs in complex therapy of chronic colitis and enterocolitis. Antibiotiki 17(3): 280-284

Bourgeois, P.; Schipman, C. 1971: Antibacterial drugs in the treatment of bronchopulmonary suppurations (apropos of the trial of a new bactericide). Therapeutique 47(4): 351-356

Filadoro, F.; Cipriani, P.; Ravagnan, L. 1968: Antibacterial effect in vitro and in vivo of kitasamycin. Antibiotica 6(1): 5-23

Foltínová, P.; Blöckinger, G. 1970: Antibacterial effect of 2-mercaptobenzothiazole and its derivatives. Biologia (Bratislava) 25(3): 175-180

Vidal de Johnson, B. 1973: Antibacterial effect of Ascoxal on the oral flora in patients with periodontal disease. La Tribuna Odontologica 57(7): 198 Passim

Schröter, G.; Schrettenbrunner, A. 1982: Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. 1. Abt. Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie 253(3): 355-357

Hayashi, S.; Yamamoto, S.; Go, D.; Takagi, T. 1972: Antibacterial effect of Resiguard spray in the operating room. Kango Kenkyu. Japanese Journal of Nursing Research 5(3): 317-321

Pershin, G.N.; Makeeva, O.O. 1966: Antibacterial effect of Soliutizon. Problemy Tuberkuleza 44(7): 63-67

Liedmann, E.; Ritzerfeld, W. 1974: Antibacterial effect of a new cephalosporin-derivative cephapirin. Fortschritte der Medizin 92(9): 396-398

Mössner, G.; Auwärter, W. 1972: Antibacterial effect of a new chemotherapeutic drug. Die Medizinische Welt 23(38): 1306-1309

Buranský, J.; Mlyncek, M.; Toldy, M. 1983: Antibacterial effect of amniotic fluid. Bratislavske Lekarske Listy 79(6): 685-692

Meyer-Rohn, J.; Puschmann, M. 1980: Antibacterial effect of an erythromycin-containing topical preparation on the auxanogram test. Zeitschrift für Hautkrankheiten 55(2): 114-116

Eyckmans, L.; Billiau, A.; De Somer, P. 1973: Antibacterial effect of an interferon-inducing polycarboxylate. Mechanism of action. Biomedicine / 19(5): 187-192

Ajao, A.O.; Femi-Onadeko, B.; Komolafe, O.O.; Shonukan, O.O. 1982: Antibacterial effect of aralkylacetic acids and their peptides. Die Pharmazie 37(9): 670

Ozbal, Y.; Fazli, S.A.; Arslan, N. 1984: Antibacterial effect of cefoperazone. Mikrobiyoloji Bulteni 18(3): 154-159

Torres, J.; Guevara, I.; Hernandez, H. 1970: Antibacterial effect of cephalexin monohydrate in urinary tract infections. La Prensa Medica Mexicana 1970: 65-68

Ritzerfeld, W.; Kleining, R. 1968: Antibacterial effect of chloramphenicol and nitrofurantoin under the effect of lysozyme. Archiv für Hygiene und Bakteriologie 152(5): 477-481

Eiferman, R.A.; Snyder, J.W. 1983: Antibacterial effect of cyanoacrylate glue. Archives of Ophthalmology 101(6): 958-960

Incze, K.; Farkas, J.; Mihályi, V.; Zukál, E. 1974: Antibacterial effect of cysteine-nitrosothiol and possible percursors thereof. Applied Microbiology 27(1): 202-205

Richardson, J.A.; Borchardt, K.A. 1972: Antibacterial effect of different dialysates. British Medical Journal 2(5811): 468-469

Povelitsa, F.D.; Gural', A.G. 1973: Antibacterial effect of furacriline on Brucella. Antibiotiki 18(1): 71-74

Weissenborn, K. 1969: Antibacterial effect of gentamicin in the scope of routine antibiogramms. Arzneimittel-Forschung 19(7): 1132-1135

Dandegaonker, S.H.; Revnakar, G.R. 1968: Antibacterial effect of halogen benzimidazoles. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 301(3): 177-178

Ritzerfeld, W.; Nelke, H. 1970: Antibacterial effect of lincomycin and 7-chloro-7-desoxylincomycin (Sobelin). Archiv für Hygiene und Bakteriologie 154(1): 37-41

Prát, V.; Konícková, L.; Ritzerfeld, W.; Losse, H. 1968: Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis. Arztliche Forschung 22(2): 69-72

Konícková, L.; Prát, V.; Ritzerfeld, W.; Losse, H. 1968: Antibacterial effect of nitrofurantoin in acute, ascending E. coli pyelonephritis of rats. Arzneimittel-Forschung 18(6): 720-722